WO2011054174A1 - Depolymerized fucosylated glycosaminoglycan and preparation method thereof - Google Patents

Depolymerized fucosylated glycosaminoglycan and preparation method thereof Download PDF

Info

Publication number
WO2011054174A1
WO2011054174A1 PCT/CN2010/001679 CN2010001679W WO2011054174A1 WO 2011054174 A1 WO2011054174 A1 WO 2011054174A1 CN 2010001679 W CN2010001679 W CN 2010001679W WO 2011054174 A1 WO2011054174 A1 WO 2011054174A1
Authority
WO
WIPO (PCT)
Prior art keywords
salt
ester
dfg
amine
depolymerization
Prior art date
Application number
PCT/CN2010/001679
Other languages
French (fr)
Chinese (zh)
Inventor
赵金华
吴明一
康晖
曾伟珍
梁慧
李姿
徐世民
冯汉林
于琳
Original Assignee
深圳海王药业有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳海王药业有限公司 filed Critical 深圳海王药业有限公司
Publication of WO2011054174A1 publication Critical patent/WO2011054174A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Definitions

  • the invention belongs to the technical field of medicine, and relates to a method for preparing a xyloganose (dFG) and a preparation method thereof, and a medicine group containing the same.
  • Background technique a xyloganose (dFG) and a preparation method thereof, and a medicine group containing the same.
  • Fucosylated Glycosaminoglycan Fucose-branched Glycosamino- glycan or fiicose-containing glycosaminoglycan (FG for short), or Fucosylated chondroitin sulfate (FCS) refers to a kind of skin animal
  • a glycosaminoglycan derivative having a structure similar to that of chondroitin, but having a sucrose substitution in the body wall or viscera J Biol Chem, 1988, 263 (34): 18176-83 and J Biol Chem, 1991, 266 (21) : 13530-6 X
  • Natural FG has ⁇ activity (Fan et al., Pharmacological Journal, 1980, 15: 267), which has potential therapeutic effects on certain blood pine diseases, but FG also has induced platelet aggregation activity (Jia- Zeng Li et al, Thronbosis and Haemostasis, 1988, 54(3): 435-9), and platelet-inducing activity severely affects the conversion of the potential therapeutic effects of FG to actual clinical applications. Recent studies have shown that i-quantity FG can retain a certain intensity of activity while eliminating or avoiding the platelet-inducing activity of prototypic polysaccharides (Fan et al., J. Biol. Chem., 1993, 9(2): 146- 151; Toshio Imanari et al, T3 ⁇ 4rombosis Research, 1997, 129: 27-31).
  • Low molecular weight FG can be derived from the fractionation of FG or from FG depolymerization.
  • Hierarchical treatment [ ⁇ FG method is simple (Fan et al., J. Biol. Chem., 1993, 9 (2): 146-151), but due to the fact that there are few ⁇ in the natural FG, the system is divided into two parts. ⁇ flFG has a low yield and a serious waste of resources.
  • Enzymatic depolymerization and nitrous acid depolymerization methods commonly used for glycosaminoglycan depolymerization are not suitable for depolymerizing FG because: the presence of fucose bismuth makes known glycosaminoglycan endonucleases impossible. Hydrolyzed FG; ⁇ in the FG are all B-Tang, no free, so no ⁇ fclLE Xiao poly.
  • glycosidic bonds in FG Due to the existence of many different types of glycosidic bonds in FG, such as glucuronic acid (GlcUA) ⁇ (1 ⁇ 3) glycosidic bonds present in the main chain, acetylaminogalactose (GalNAc) ⁇ (1 ⁇ 4) sugars, and Tender ⁇ -fucose (Fuc) sugar truncation, etc., conventional 3 ⁇ 4 (3 ⁇ 4 depolymerization method has limited choice of these glycosidic bonds.
  • GlcUA glucuronic acid
  • GalNAc acetylaminogalactose
  • Fuc Tender ⁇ -fucose
  • Non-selective cleavage of the backbone glycosidic bond can form oligomeric groups with different '
  • the FG product that is, the higher G?UA and GalNAc ends of the higher I:, thus affecting the homogeneity of the product; and the cleavage of the side-glycosidic bond can lead to the detachment of the side chain by the algalose.
  • One object of the present invention is to overcome the deficiencies of the technology, and to provide uniform and controllable turbidity to prepare a highly reproducible oligomeric fucosylated glycosaminoglycan (Depolymerized fucose-containing glycosaminoglycan, called dFG). Or a method of oligomeric FG).
  • the method for preparing dFG according to the present invention comprises depolymerizing fucose strip glycan (FG) by catalytic depolymerization using a catalyst containing a fourth period ⁇ > metal ion in a medium, comprising the following steps:
  • the fucose ⁇ #amine polyglycoside G) of the reference source refers to an acid mucopolysaccharide containing the fucoid 4 extracted and extracted from the animal of the sea cucumber family. Its structural characteristics are: GlcUA (gluconic acid) and GaJNAc (2-M2-J ⁇ N-B-semitylate) exist in near-equal molar ratio (1:1 ⁇ 0.3) And GlcUA and GaJNAc are linked to each other by ⁇ 1 ⁇ 3 and ⁇ 1 ⁇ 4 sugar, respectively, and the fucose (Fuc) or its sulfate is linked to the main chain in a side chain, in terms of molar ratio, Fuc
  • the GalNAc ratio can range from about 0.5 to 2.5.
  • the FG backbone structural unit can be expressed as equation (I):
  • -OR is a group (-OH), a sulfate group (-OS (V), or a chelate-fucosyl group represented by the formula ( ⁇ ):
  • -OR is a hydroxyl group (-OH), and an acid ester group (-OS0 3 - ) is as defined above.
  • the proportion of side chain fucose bismuth from FG from different sea cucumber species/variety and its linkage to the main chain position may be different; the same sea cucumber varieties but different tissue sources or differences in extraction methods may also lead to the proportion of monosaccharide composition of FG
  • the FC may be derived from sea cucumbers of different varieties, including but not limited to sea cucumber, green sea cucumber, sea cucumber, black sea cucumber, black sea cucumber, and sea cucumber.
  • step 1) the solution is carried out in a medium, and the metal ion is used as a catalyst to catalyze the solution to generate ⁇ FG.
  • the compound can generate free radicals in the ⁇ Ji system and pass through the free radical chain FG glycosidic linkages to form the dFG product.
  • peroxides include, but are not limited to, peroxyacetic acid, hydrogen peroxide, 3-chloro-perbenzoic acid, hydroperoxyolefin, sodium persulfate, benzoyl peroxide, and salts or esters thereof, preferably paste hydrogen .
  • the mass fraction of the FG in the system is about 0.05% "15%, and the mass fraction in the system is about 0.5% to about 30%.
  • the peroxide can react.
  • ⁇ ⁇ 1 ⁇ 2 can also be gradually added to the system by ⁇ or intermittent method.
  • the present invention ⁇ ⁇ will continue to add the reaction system according to the rate Medium.
  • the metal ion as a catalyst is a fourth periodic transition metal ion, including Cu+, Cu 2+ , Fe 2+ , Fe 3+ , Cr 3+ , Cr 2 0 7 2 -, Mn 2+ , Zn 2+ , Ni 2+, etc., these metal ions can be used alone or in combination with each other.
  • the catalysts are Cu+, Cu 2+ Fe 2+ , Fe 3+ , Zn 2+ , and the most ⁇ Cu 2+ . Since metal ions are not chemical reagents that exist independently, the actual organic salts of these metal ions are.
  • the concentration of the metal ion may range from about 1 nmol/L to 0.1 mol/L, and the range of ⁇ ranges from 10 nmol/L to 10 mmol/L.
  • the conventional process parameters of the depolymerization process are: a temperature range of 10 ° C to 75 ° C; a reaction time of 20 minutes to 8 hours; the reaction can be carried out under normal pressure or pressure; the reaction can be selected from nitrogen, inert gas Under protection, it can also be carried out under atmospheric pressure with the atmosphere ring*N.
  • a chelate can be added to the system to inhibit it by chelation with the metal ion catalyst. Then it is terminated by technical means such as ⁇ P, and agent.
  • refers to a physical shield capable of forming a metal ion, including but not limited to ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), 3-propylenediaminetetraacetic acid (PDTA), Triacetic acid ammonia (NTA) or a salt thereof.
  • EDTA ethylenediaminetetraacetic acid
  • DTPA diethylenetriaminepentaacetic acid
  • PDTA 3-propylenediaminetetraacetic acid
  • NTA Triacetic acid ammonia
  • the process of the invention is preferably disodium edetate or a hydrate thereof.
  • the reaction product precipitation method is a method of adding a chelating agent to a system of a polysaccharide material by adding a salt (for example, potassium acetate), and the hydrazine solvent includes decyl alcohol, ethanol, acetone, and the like. Low carbitol/ketone, of which ethanol and acetone are preferred.
  • the reaction product dFG can be purified by methods known in the art, for example by dialysis or ultrafiltration. ⁇ "Salt, further purification by means of analysis or DEAE ion exchange, etc., the obtained dFG product can also be prepared by cation exchange to prepare a single salt form, such as sodium salt, potassium salt or calcium salt, etc. In the middle, the amount of dFG can be 4%.
  • the molecular weight of the dialysis membrane should be cut off, and the molecular weight cut off should be 3000 Da.
  • the dialysis time should be determined by specific treatment conditions, usually not less than 6 hours.
  • the dynamic ion exchange salt method, wherein the strong acid cation exchange resin can be selected for use.
  • the pretreatment of the tree column, the sample loading and the sample can be carried out according to the usual method.
  • the sample mass of the sample of the ⁇ 4 in the method of the invention ⁇ about 2 ° / ⁇ 5%
  • the method of the invention can significantly improve the reaction conditions of the ruthenium peroxide depolymerization FG, that is, when the same peroxide or the original FG starting material is used to prepare the same or near-order amount of dFG, at temperature and the like
  • the method can increase the reaction rate and shorten the reaction time course relative to the direct i3 ⁇ 4 compound depolymerization method (ie, the method of peroxide depolymerization in the absence of a metal ion catalyst); similarly, in controlling the reaction time Under the conditions, the method of the invention can significantly lower the temperature required for the reaction, so that the desired JS can be completed at room temperature.
  • the batch-to-batch variation of the products obtained by the method of the present invention was significantly lower than that of the direct oxide depolymerization method under the same or similar ⁇ cattle.
  • the method of the present invention can be conveniently achieved by changing the conditions, and for the direct peroxide depolymerization method, the uncertainty of changing the post-cow reaction product deviation from the expected result is more serious (the obtained dFG)
  • the difference between the amount and the target molecular weight can reach 5% or more).
  • the method of the invention significantly improves the repeatability and controllability of the preparation of dFG, which may be related to the activation energy of the catalyst and the steady rate of the shape, and may also shorten the temperature and the time course to shorten the isothermal bovine and its cattle. Controllability is related to qualitative improvement.
  • the product obtained by the process of the invention has a high degree of repeatability under the same reaction conditions; however, for the FG "crude polysaccharide" containing more impurity components, the depolymerization reaction
  • the stability and controllability of the present invention are still quite different.
  • the present inventors have now found that the presence of an organic salt having a certain ionic strength in the reaction system can improve the stability of the solution.
  • the present invention provides a method for improving and improving the controllability of FG solution, that is, adding a certain concentration of ⁇ / or organic to a metal ion-catalyzed system of lyophilized polysaccharides. salt.
  • the i ⁇ bM ⁇ / or organic salt includes a salt formed of a metal element (such as an alkali metal, a metal element, etc.) with a halogen, an organic acid, or the like, a salt of an organic or inorganic acid and an organic base, and a combination thereof. Salt, which evades sodium chloride, chlorinated clock, sodium acetate, sodium acetate trihydrate, acetic acid clock.
  • the salt ion concentration of the valence or organic salt used for improving the depolymerization and the controllability of the reaction is from about 0.1 mmol/L to about 1.0 mol/L.
  • the mechanism by which salt ions improve the J ⁇ H cattle cannot be fully elucidated.
  • it may be related to the conformation of the stable reactant FG.
  • the FG of the present invention is a fucose t-aminoglycan derived from the echinoderms of the echinoderms, which is characterized by the presence of GlcUA and GalNAc ( ⁇ -ester) in a molar ratio of about 1:1 ⁇ 0.3 and different molar ratios. Fucose Acid ester). Differences in sea cucumber varieties and their tissue sources or differences in extraction methods may lead to differences in the ratio of monosaccharides, the forms of existence, and the degree of sulfate in the polysaccharides of FG, but these differences do not involve the essential changes in the type of FG structural polyglycoside bonds. Therefore, the practical application of the depolymerization method of the present invention is not affected.
  • the source animal of the FG of the present invention may be selected from, but not limited to, sea cucumber, green sea cucumber, sea cucumber, black sea cucumber, black sea cucumber, and ginseng.
  • sea cucumber green sea cucumber
  • sea cucumber sea cucumber
  • black sea cucumber black sea cucumber
  • ginseng the fucosylated glycosaminoglycans of the above-mentioned structural features can be depolymerized by the method of the present invention to obtain the desired
  • the oligomeric FG product therefore, is not limited by the particular sea cucumber variety.
  • the reduced end of the dFG product obtained in the present invention can be detected by NMR.
  • NMR detection can also be conveniently used to confirm the Fuc/GaJNAc composition ratio in the product.
  • the present inventors Comparing the direct i3 ⁇ 4 compound depolymerization with the catalytic compound depolymerization product, the present inventors have found that the Mh depolymerization method has an unexpected sugar ⁇ It is less than 80% or more than 95%) and less than GlcUA, which is different from the direct depolymerization product in the high GfUA end of the GfUA, indicating that the dFG obtained by the catalytic peroxide depolymerization method is better. End uniformity, thus better quality uniformity and controllability
  • the ratio may have about 5% enthalpy, which proves the choice of the sugar of the method of the present invention.
  • another object of the present invention is to provide an oligomeric FG (dFG) prepared by the method of the present invention, wherein the dFG has a terminal mainly of GalNAc and is subjected to nuclear magnetic resonance (NMR) technology. It can be confirmed that the composition ratio thereof is not less than 80%, and accordingly, in the dFG, the number of glycans in which GlcUA is used as the reduction 'f sister' is less than 20%. In the dFG of the present invention, the number of polysaccharides having GalNAc as 4 sisters is not less than 90%.
  • the amount of dFG product can be measured by high-efficiency sword-cross chromatography.
  • Reserved FG jk3 ⁇ 4 from active learning in 1 ⁇ 2-induced platelet aggregation activity Free considerations, weight average ⁇ meter, the present invention is selected from ⁇ £ ⁇ ⁇ 0 in an amount ranging from about 6,000 ⁇ 20,000Da, V escape molecular weight ranging from about 10,000 to 15,000 Da.
  • the multi-dimensional index (PDI, ratio of weight average molecular weight to number average molecular weight, Mw/Mn) of the dFG of the present invention is between 1.0 and 2.0; for the oligomeric FG of bismuth, the PDI is 1.2. Between 1.6.
  • the dFG of the present invention may be a salt of a pharmaceutically acceptable alkali metal, a metal or the like, such as a sodium salt, a potassium salt and a calcium salt; and the like, and the oligomeric FG of the present invention may also be a pharmaceutical thereof.
  • An acceptable ester of an alkaline organic group may be used.
  • the dFG of the present invention has an exact activity and thus has a clear pharmaceutical potential.
  • dFG has a good water solubility and is therefore easy to prepare into a solution preparation or a lyophilized product thereof.
  • the use of the material is limited, due to the preparation of the gastrointestinal preparation dosage form, the preparation of the preparation can be in accordance with the field Well-known technical methods are carried out.
  • a further object of the present invention is to provide a pharmaceutical composition comprising the dFG of the present invention and a pharmaceutically acceptable excipient.
  • Figure 1 shows the HPGPC spectrum of FG and its degradation product dFG
  • 2 is a 1 H NMR spectrum showing a Fuc/GalNA molar ratio (integral area ratio of a thiol signal) in FG and dFG;
  • Figure 3A is a ⁇ - 1 !! COSY spectrum of dFG-2;
  • Figure 3B is a cross-section of the COSY spectrum at 5.22 ppm of Figure 3A showing the NMR signals of the ⁇ - ⁇ of the reducing ends GalNAc and GlcUA.
  • TSP-D4 trimethylsilyl-propionic acid
  • Mw weight average ⁇ ⁇ quantity
  • Mn number average
  • the GalNAcFuc molar ratio (the fucose sulfhydryl peak signal is about 1.3 ppm, and the 33 ⁇ 4 ⁇ 1/2 tang ⁇ base peak is about 2.1 ppm), dFG-1 is more FG. About 9%, while dFG-2 did not change. In the presence of Cu 2+ ions, ⁇ 2 (3 ⁇ 4 depolymerized FG has no effect on the fucoids. Obviously, according to the direct ⁇ t ⁇ solution, the Fuc ratio of dFG-1 is changed. It can be judged that the direct depolymerization can lead to the formation of "alcohol".
  • the molar ratio of GalNAc and GlcUA at the depolymerization product end can be judged, wherein the non-reducing end and the bridgehead hydrogen of GalNAc and GlcUA in the polysaccharide main chain are both ⁇ -configuration, and the NMR signal appears to be about 4.4 to 4.6 ppm. Meanwhile, the 'ends of GaJNAc and GlcUA each have about half of the ⁇ -configuration bridgehead hydrogen.
  • the ⁇ -configuration bridgehead hydrogen of GalNAc and GlcUA is about 5.2 ⁇ 5.3 ppm, which is difficult to distinguish between them, but the H2# ⁇ J chemistry associated with them is about 4.2 ⁇ 4.5 ppm.
  • 3.6 ⁇ 3.9 ppm so it can be seen in the "PuD" to distinguish (the prototype FG due to ⁇ " large amount, the number of terminal glycosyl groups is small and it is difficult to obtain a sufficiently strong distinguishing signal).
  • the research of the present invention shows that the metal ion catalysis can significantly improve the selection of the sugar bit bond by the it ⁇ t ⁇ depolymerization method.
  • a certain choice of f is shown, ⁇ "the exact mechanism is unknown.
  • the selection of the catalytic solution of the present invention should be matched with the catalyst.
  • the effects of activation energy of free radicals of different types of sugars ⁇ ⁇ are related.
  • the results of the present invention are 1 ⁇ 2i3 ⁇ 4.
  • the number of glycan molecules with GalNAc as the reducing end in the dFG product is usually more than 80%, and in this embodiment, GalNAc is used as '
  • the ratio of the 13 ⁇ 4 end is 95%.
  • Example 3 Comparison of repeatability and controllability of dFG prepared by direct ⁇ depolymerization and metal ion catalysis ijA depolymerization
  • Ethanol' fixed polysaccharide, centrifuged; J, washed twice with 0.6L of 60% ethanol, then dissolved in 10L of water with a cut-off of 3000Da modified cellulose 3 ⁇ 4 filter, 6 hours, cut off the product, freeze-dried, calculate the product Rate and detect the amount of product and its distribution.
  • Cu 2+ catalyzed dehydrogenation of FG by hydrogen peroxide 300 g of each of the five sea cucumbers FG was dissolved in 9 L of water, 45. C water bath insulation and continuous uniformity of 4 and a half, then add 0.6L pure water or 20mmol / L concentration of copper acetate (Cu 2+ ) solution, and then add 15% H 2 0 at a rate of 0.6L / h within 2 hours 2 , ⁇ process with 1 N NaOH solution to control the pH range of 7.2 ⁇ 7.8.
  • Mw weight average
  • Mn number average ⁇ ⁇ quantity
  • PDI quantity more ⁇ L index
  • Cu 2+ catalyzed hydrogenation of FG 5.0 g of crude polysaccharides of five parts of jade ginseng dissolved in a circle; 190 ml of water in a bottle, 35. C water bath ⁇ ⁇ and ⁇ uniform halving, then add 50mmol / L concentration of copper acetate (Cu 2+ ) solution 10ml, then add 10% H 2 0 2 at a rate of 10ml / h, 1 N during the reaction
  • the NaOH solution controls the pH range from 7.2 to 7.8.
  • Mw weight average ⁇ "quantity
  • Mn number average ⁇ ⁇ quantity
  • PDI ⁇ ⁇ quantity more ⁇ t index
  • Adding a certain intensity of non-organic or organic ions to the reaction medium can significantly improve the reproducibility of the depolymerization reaction, although the addition of these ions may be a certain degree of enthalpy.
  • ⁇ or the mechanism by which organic ions improve the repeatability of the reaction is not fully understood and may be thought to be related to maintaining a stable conformation of the polysaccharide.
  • the related research of the present invention shows that in the ⁇
  • Example 5 ⁇ k activity of low saccharose ⁇ ⁇ teratamine (dFG)
  • the series of jade ginseng dFG: Mw are 25,380, 18,050, 14,350, 11,450, 8,800 respectively. Prepared according to Cu 2+ catalyzed depolymerization method in Example 4. (dimerization time is different);
  • Reagents rabbit anemia small ⁇ pulp, Guangzhou Rui Te Biotechnology Co., Ltd.;
  • Activated partial thromboplastin time ( ⁇ ) assay kit (ellagic acid): Shanghai Sun Biotechnology Co., Ltd.
  • Table 5 Effect of different molecular weight dFG derived from Jade foot sea cucumber on plasma sputum time in rabbits
  • Freeze-drying process Place the sample into the box and lower the partition to >0. C, hold 3h; cold trap drops to -50. C, start pumping vacuum to 300nbar. Start sublimation: lh heat up to -30 at a constant rate. C, ⁇ 2h; 2h at a constant rate to -20. C,

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Disclosed is a method for preparing depolymerized fucosylated glycosaminoglycans which are obtained by depolymerizing fucosylated glycosaminoglycans through peroxide depolymerization catalyzed by the fourth period transition metal ions in water phase medium. The depolymerized fucosylated glycosaminoglycans obtained have no less than 80% of glycan molecular number taking GaINAc as reductive terminal, and weight average molecular weight of which is about 6000Da~ 20,000Da, and PDI of which is 1.0- 2.0.

Description

»^藻糖 胺 及其制备方法 技术领域  »^藻amine and its preparation method
本发明属于医药技术领域, 地说, 涉及一种 ^藻糖^ ^胺聚糖(dFG ) 及其制备方法, 以及含有该 ^藻糖 ^*唐胺聚糖的药物组^^。 背景技术  The invention belongs to the technical field of medicine, and relates to a method for preparing a xyloganose (dFG) and a preparation method thereof, and a medicine group containing the same. Background technique
岩藥糖化糖胺聚糖 ( Fucosylated Glycosaminoglycan, Fucose-branched Glycosamino- glycan或 fiicose-containing glycosaminoglycan, 简称 FG ),或 ^为岩藻 糖 嫩软骨素 ( Fucosylated chondroitin sulfate, FCS ), 是指一类 皮动物体壁或 内脏中提减得的, 具有类似于石 软骨素主 构, 但具有柳腱 糖取代 的糖胺聚糖衍生物 ( J Biol Chem, 1988, 263 (34): 18176-83和 J Biol Chem, 1991, 266 (21) : 13530-6 X  Fucosylated Glycosaminoglycan, Fucose-branched Glycosamino- glycan or fiicose-containing glycosaminoglycan (FG for short), or Fucosylated chondroitin sulfate (FCS), refers to a kind of skin animal A glycosaminoglycan derivative having a structure similar to that of chondroitin, but having a sucrose substitution in the body wall or viscera (J Biol Chem, 1988, 263 (34): 18176-83 and J Biol Chem, 1991, 266 (21) : 13530-6 X
天然 FG具有^ 活性(樊绘曾等, 药学学报, 1980, 15: 267 ),此活性使^† 于某些血松 f生疾病具有潜在治疗作用,然而 FG同时具有诱导血小板聚集活性 (Jia- zeng Li等, Thronbosis and Haemostasis, 1988, 54(3): 435-9 ), 而血小板诱导活性严重 影响了 FG潜在治疗作用向实际临床应用的转化。 近年来的研究资料显示, i - 量 FG可^^保留一定强度的^ 活性的同时消除或避免原型多糖的血小板诱导 活性(樊绘曾等,生物化学杂志, 1993, 9(2): 146-151; Toshio Imanari等, T¾rombosis Research, 1997, 129: 27-31 )。  Natural FG has ^ activity (Fan et al., Pharmacological Journal, 1980, 15: 267), which has potential therapeutic effects on certain blood pine diseases, but FG also has induced platelet aggregation activity (Jia- Zeng Li et al, Thronbosis and Haemostasis, 1988, 54(3): 435-9), and platelet-inducing activity severely affects the conversion of the potential therapeutic effects of FG to actual clinical applications. Recent studies have shown that i-quantity FG can retain a certain intensity of activity while eliminating or avoiding the platelet-inducing activity of prototypic polysaccharides (Fan et al., J. Biol. Chem., 1993, 9(2): 146- 151; Toshio Imanari et al, T3⁄4rombosis Research, 1997, 129: 27-31).
低分子量 FG可以来自 FG的分级处理, 也可以来自 FG解聚。 分级处理所 [氐 Ή FG方法简单(樊绘曾等,生物化学杂志, 1993, 9 (2): 146-151 ), 但由于天然 FG 中所^ ^且 支少, 分^ t理法制 ^i^flFG的得率较低而且资源浪费严重。  Low molecular weight FG can be derived from the fractionation of FG or from FG depolymerization. Hierarchical treatment [氐Ή FG method is simple (Fan et al., J. Biol. Chem., 1993, 9 (2): 146-151), but due to the fact that there are few ^ in the natural FG, the system is divided into two parts. ^flFG has a low yield and a serious waste of resources.
常用于糖胺聚糖解聚的酶法解聚、亚硝酸解聚方法均不适合于解聚 FG,其原因 在于: 岩藻糖 臌的存在使得已知的糖胺聚糖内切酶均不能水解 FG; FG中的 ^均为乙 唐, 无游离 在, 因而不 ^fclLE肖 聚。  Enzymatic depolymerization and nitrous acid depolymerization methods commonly used for glycosaminoglycan depolymerization are not suitable for depolymerizing FG because: the presence of fucose bismuth makes known glycosaminoglycan endonucleases impossible. Hydrolyzed FG; ^ in the FG are all B-Tang, no free, so no ^fclLE Xiao poly.
¾02法解聚 FG已见于 ^gJi ( Fan Hui-Zeng等, WO 90/08784; Ken-ichiro Yoshida 等, Tetrahedron Lettere, 1992, 33 (34)4959-62 )。 由于 FG中存在多种不同类型的糖苷 键, 例如存在于主链的葡萄糖醛酸(GlcUA) β(1→3)糖苷键、 乙酰氨基半乳糖 (GalNAc) β(1→4)糖 以及存在于嫩的 α-岩藻糖(Fuc ) 糖截等, 常规 ¾(¾ 解聚方法对这些糖苷键的选择 4生有限。 非选择性裂解主链糖苷键可以形成具有不同 的 '|¾端的低聚 FG产物, 即同时存在较高^ I:的 GlcUA及 GalNAc末端, 因 而影响产物的均一性; 而侧^唐苷键的裂解可以导 ¾ ^藻糖取代侧链的脱落。 The 3⁄40 2 method depolymerization FG has been found in ^gJi (Fan Hui-Zeng et al, WO 90/08784; Ken-ichiro Yoshida et al, Tetrahedron Lettere, 1992, 33 (34) 4959-62). Due to the existence of many different types of glycosidic bonds in FG, such as glucuronic acid (GlcUA) β(1→3) glycosidic bonds present in the main chain, acetylaminogalactose (GalNAc) β(1→4) sugars, and Tender α-fucose (Fuc) sugar truncation, etc., conventional 3⁄4 (3⁄4 depolymerization method has limited choice of these glycosidic bonds. Non-selective cleavage of the backbone glycosidic bond can form oligomeric groups with different '|3⁄4 ends The FG product, that is, the higher G?UA and GalNAc ends of the higher I:, thus affecting the homogeneity of the product; and the cleavage of the side-glycosidic bond can lead to the detachment of the side chain by the algalose.
^b, 常规 H202法解聚?0所需 ^牛相对剧烈, 其^ ί温度要求较高、 反 应时间较长, 而其关键性缺陷在于, 该 的可控性和重复性 。 ^b, conventional H 2 0 2 method depolymerization? 0 required ^ cattle relatively intense, its ^ ί temperature requirements are higher, anti It should take a long time, and its key flaw is the controllability and repeatability.
因此, 开发一种 牛温和、 重现性高、 产物均一性好的制 ^ FG的方 法对 FC的工业化生产具有重大意义。 发明内容  Therefore, the development of a method for the production of FG with mild, reproducible and uniform product homogeneity is of great significance for the industrial production of FC. Summary of the invention
本发明的一个目的在于克 ^W技术的不足, 提^ ""种制备盾量均一可控, 制 备重复性高的低聚岩藻糖化糖胺聚糖 ( Depolymerized fucose-containing glycosaminoglycan, 筒称为 dFG或低聚 FG )的方法。  One object of the present invention is to overcome the deficiencies of the technology, and to provide uniform and controllable turbidity to prepare a highly reproducible oligomeric fucosylated glycosaminoglycan (Depolymerized fucose-containing glycosaminoglycan, called dFG). Or a method of oligomeric FG).
本发明所述制备 dFG的方法是在 目介质中采用含有第四周期±>度金属离子的 催化剂, 催化 解聚法解聚岩藻糖條胺聚糖(FG), 包括以下步骤: The method for preparing dFG according to the present invention comprises depolymerizing fucose strip glycan (FG) by catalytic depolymerization using a catalyst containing a fourth period ±> metal ion in a medium, comprising the following steps:
1 )在第四周期 i±¾金属离子的催化剂存在下, 在 目介盾中, 加入 i±| ^/以 解 参来源的岩藻糖^ ^唐胺聚糖; 1) In the presence of a catalyst of i±3⁄4 metal ion in the fourth cycle, add i±| ^/ to the fucose-derived glycosaminoglycan from the target medium shield;
2)中止^ J^, 收集和纯化所需^ 量范围的#¾^藻糖^胺聚糖。  2) Suspend ^ J^, collect and purify the required amount of #3⁄4^藻糖-aminoglycan.
步骤 1 )中,所 参来源的岩藻糖^#胺聚卿 G)是指Λ^皮动物门海参纲所 述动物中提取制备的含有岩藻 4 且分的酸性粘多糖。 其结构特征是: 在其单 且成 中, GlcUA (葡萄糖酸酸)和 GaJNAc ( 2-M2- J^N-乙 -半 ty^嫩酯) 以近于等摩尔比(1:1±0.3)存在, 且 GlcUA与 GaJNAc分别以 β1→3和 β1→4糖 ^^相互连接构成多糖主链, 岩藻糖(Fuc)或其硫酸酯以侧链形式连接于主链,, 以 摩尔比计, Fuc:GalNAc比值范围可以是约 0.5~2.5。 FG主链结构单元可表示为式 (I):  In the step 1), the fucose ^#amine polyglycoside G) of the reference source refers to an acid mucopolysaccharide containing the fucoid 4 extracted and extracted from the animal of the sea cucumber family. Its structural characteristics are: GlcUA (gluconic acid) and GaJNAc (2-M2-J^N-B-semitylate) exist in near-equal molar ratio (1:1±0.3) And GlcUA and GaJNAc are linked to each other by β1→3 and β1→4 sugar, respectively, and the fucose (Fuc) or its sulfate is linked to the main chain in a side chain, in terms of molar ratio, Fuc The GalNAc ratio can range from about 0.5 to 2.5. The FG backbone structural unit can be expressed as equation (I):
Figure imgf000003_0001
式(I)中: -OR为 基(-OH)、 硫酸酯基(-OS(V)、 或为如式(Π)所示的 碰酯化岩藻糖基:
Figure imgf000003_0001
In the formula (I): -OR is a group (-OH), a sulfate group (-OS (V), or a chelate-fucosyl group represented by the formula (Π):
Figure imgf000003_0002
式(Π )中: -OR为羟基(-OH)、 酸酯基(-OS03- )定义同上式。
Figure imgf000003_0002
In the formula (Π): -OR is a hydroxyl group (-OH), and an acid ester group (-OS0 3 - ) is as defined above.
来自不同海参种属 /品种的 FG的侧链岩藻糖基 ϋ比例及其连接于主链位置方 式可以存在差异; 海参品种相同但组织来源不同或者提取方法差异也可能导致 FG 的单糖组成比例、 侧链存在形式以及多糖 跛^ f呈度等方面的不同, 但是这些差异 均不涉及 FG结构特征和糖苦键类型的本盾变化, 不影响本发明所述方法的有效实 应用。 因此, ^^发明中, 所述 FC可来源于世^^地不同品种的海参, 包括但 不限于刺参、 绿刺参、 玉足海参、 黑海参、 黑乳海参、 糙海参等。  The proportion of side chain fucose bismuth from FG from different sea cucumber species/variety and its linkage to the main chain position may be different; the same sea cucumber varieties but different tissue sources or differences in extraction methods may also lead to the proportion of monosaccharide composition of FG There are differences in the form of side chain and the degree of polysaccharide formation, but these differences do not involve the FG structural characteristics and the changes of the sugar bond type, and do not affect the effective application of the method of the present invention. Therefore, in the invention, the FC may be derived from sea cucumbers of different varieties, including but not limited to sea cucumber, green sea cucumber, sea cucumber, black sea cucumber, black sea cucumber, and sea cucumber.
步骤 1 )中,解^:在 ^目介质中进行,釆用金属离子作为催化剂催化 勿 的解 ¾½, 以生成 ^^ FG。  In step 1), the solution is carried out in a medium, and the metal ion is used as a catalyst to catalyze the solution to generate ^^ FG.
所述¾化物可以在 ^Ji体系中产生自由基, 并通过自由基链 FG 糖苷键,进而形成所述 dFG产物。这些过氧化物包括但不限于过氧乙酸、过氧化氢、 3-氯 -过苯甲酸、 氢过氧 烯、 过硫酸钠、 过氧化苯甲酰以及它们的盐或酯, 优选 为糊匕氢。  The compound can generate free radicals in the ^Ji system and pass through the free radical chain FG glycosidic linkages to form the dFG product. These peroxides include, but are not limited to, peroxyacetic acid, hydrogen peroxide, 3-chloro-perbenzoic acid, hydroperoxyolefin, sodium persulfate, benzoyl peroxide, and salts or esters thereof, preferably paste hydrogen .
所述 FG在^^体系中的质量分数约为 0.05%"15%, i± ^ 在 体系中的 质量分数约为 0.5%至约 30%。 FG的解聚 过程中, 过氧化 物可以在反应 前一次性^加 T ^^ i体系中, 也可以采用 ^或断续性方式将 ^ ^½物 逐步加入到 体系中。 本发明^ ^将 化物 物按照可 ^ i率的方式持续加 反应体系中。  The mass fraction of the FG in the system is about 0.05% "15%, and the mass fraction in the system is about 0.5% to about 30%. During the depolymerization of FG, the peroxide can react. In the former one-time ^ plus T ^ ^ i system, ^ ^ 1⁄2 can also be gradually added to the system by ^ or intermittent method. The present invention ^ ^ will continue to add the reaction system according to the rate Medium.
所述作为催化剂的金属离子为第四周期过渡金属离子, 包括 Cu+、 Cu2+、 Fe2+、 Fe3+、 Cr3+、 Cr207 2-、 Mn2+、 Zn2+、 Ni2+等, 这些金属离子可以单独^ 1 , 也可以相 互组^ 为复^ ί崔化剂 。 其中, 的催化剂为 Cu+、 Cu2+ Fe2+、 Fe3+、 Zn2+, 最^^为 Cu2+。 由于金属离子并非独立存在的化学试剂, 实际^的是这些金属离 子的无才^有机盐。 在反应体系中, 所述金属离子的浓度范围可以为约 l nmol/L ~ 0.1mol/L, ^ 的 范围为 10nmol/L ~ 10mmol/L。 The metal ion as a catalyst is a fourth periodic transition metal ion, including Cu+, Cu 2+ , Fe 2+ , Fe 3+ , Cr 3+ , Cr 2 0 7 2 -, Mn 2+ , Zn 2+ , Ni 2+, etc., these metal ions can be used alone or in combination with each other. Among them, the catalysts are Cu+, Cu 2+ Fe 2+ , Fe 3+ , Zn 2+ , and the most ^ Cu 2+ . Since metal ions are not chemical reagents that exist independently, the actual organic salts of these metal ions are. In the reaction system, the concentration of the metal ion may range from about 1 nmol/L to 0.1 mol/L, and the range of ^ ranges from 10 nmol/L to 10 mmol/L.
所述解聚 过程的常规工艺参数为: 温度范围为 10°C ~ 75°C;反应时间为 20 分钟 ~ 8小时;反应可以在常压或加压条件下进行;反应可以选择氮气、惰性气体保 护下进行, 也可以在常压条件下与大气环 *N通进行。  The conventional process parameters of the depolymerization process are: a temperature range of 10 ° C to 75 ° C; a reaction time of 20 minutes to 8 hours; the reaction can be carried out under normal pressure or pressure; the reaction can be selected from nitrogen, inert gas Under protection, it can also be carried out under atmospheric pressure with the atmosphere ring*N.
反应结束时, 可以向 体系中加入螯^ ^使之与金属离子催化剂螯合而抑制
Figure imgf000004_0001
继而通过^ P、 有 剂^定等技术手段终止 。 ^^是指能 与金属离子形成 ^^的物盾, 其包括但不限于乙二胺四乙酸(EDTA )、 二乙烯三 胺五乙酸(DTPA )、 3-丙二胺四乙酸(PDTA )、 三乙酸基氨(NTA )或它们的盐。 本发明方法优选乙二胺四乙酸二钠或其水合物。 反应产物沉淀法 -接或在进一步 加 几盐(如乙酸钾)的^ ί牛下加入有才 剂使聚糖类物质 体系中析出的 方法, 所述有枳溶剂包括曱醇、 乙醇、 丙酮等低威醇 /酮, 其中优选为乙醇和丙酮。
At the end of the reaction, a chelate can be added to the system to inhibit it by chelation with the metal ion catalyst.
Figure imgf000004_0001
Then it is terminated by technical means such as ^ P, and agent. ^^ refers to a physical shield capable of forming a metal ion, including but not limited to ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), 3-propylenediaminetetraacetic acid (PDTA), Triacetic acid ammonia (NTA) or a salt thereof. The process of the invention is preferably disodium edetate or a hydrate thereof. The reaction product precipitation method is a method of adding a chelating agent to a system of a polysaccharide material by adding a salt (for example, potassium acetate), and the hydrazine solvent includes decyl alcohol, ethanol, acetone, and the like. Low carbitol/ketone, of which ethanol and acetone are preferred.
反应产物 dFG可以通过本领域已知方法纯化, 例如通过透析法或超滤法去除小 ^"盐,通过^ ^析或 DEAE离子交 ^析进一步纯化等, 所得 dFG产物还可以 通过阳离子交换以制备成单盐形式, 如钠盐、 钾盐或钙盐等。 所 析去杂处理过 程中, 可 4財居目地 dFG 量大小要^^ 宜截留 量的透析膜, 截留分 子量为 3000 Da。透析时间需 ^特定处理条件确定,通常不少于 6小时。 dFG产物 的成盐过程 ύ ^动态离子交城盐法, 其中可选择釆用强酸性阳离子交换树脂。 树 月旨柱预处理、 样品上样与 -^¾均可按常 法进行。 本发明方法中 ύί4的样品上样 质量分^约 2°/ ^ 5%。 The reaction product dFG can be purified by methods known in the art, for example by dialysis or ultrafiltration. ^"Salt, further purification by means of analysis or DEAE ion exchange, etc., the obtained dFG product can also be prepared by cation exchange to prepare a single salt form, such as sodium salt, potassium salt or calcium salt, etc. In the middle, the amount of dFG can be 4%. The molecular weight of the dialysis membrane should be cut off, and the molecular weight cut off should be 3000 Da. The dialysis time should be determined by specific treatment conditions, usually not less than 6 hours. The salt formation process of dFG product ύ ^ The dynamic ion exchange salt method, wherein the strong acid cation exchange resin can be selected for use. The pretreatment of the tree column, the sample loading and the sample can be carried out according to the usual method. The sample mass of the sample of the ύί4 in the method of the invention ^ about 2 ° / ^ 5%.
本发明方法可以显著改善过氧化凇解聚 FG的反应条件, 即, 釆用相同过氧化 物^ έ物和原型 FG起始物制备相同或近 目等^ ^量的 dFG时, 在温度等 条 件近似的情况下, 相对于直接 i¾化物解聚法(即没有金属离子催化剂存在下的过 氧化物解聚方法), 本 明方法可以提高反应速度, 缩短反应时程; 类似地, 在控制 反应时间的条件下, 本发明方法可以显著降低反应所需温度, 以至可以在室温条件 下完成所需^ JS。  The method of the invention can significantly improve the reaction conditions of the ruthenium peroxide depolymerization FG, that is, when the same peroxide or the original FG starting material is used to prepare the same or near-order amount of dFG, at temperature and the like In the approximate case, the method can increase the reaction rate and shorten the reaction time course relative to the direct i3⁄4 compound depolymerization method (ie, the method of peroxide depolymerization in the absence of a metal ion catalyst); similarly, in controlling the reaction time Under the conditions, the method of the invention can significantly lower the temperature required for the reaction, so that the desired JS can be completed at room temperature.
在 dFG的重复制备过程中, 在^ ^牛相同或近似的 ^牛下, 与直接氧化 物解聚法相比, 本发明方法所得产物的批次间差异显著 氐。 对于不同目标分子量 的 dFG制备而言, 本发明方法可以便捷地通过改变 条件而实现, 而对于直接过 氧化物解聚法, 则改变 牛后反应产物偏离预计结果的不确定性较为严重(所 得 dFG 量与目标分子量的差异可达 5%以上)。  During the repeated preparation of dFG, the batch-to-batch variation of the products obtained by the method of the present invention was significantly lower than that of the direct oxide depolymerization method under the same or similar ^ cattle. For the preparation of dFG of different target molecular weights, the method of the present invention can be conveniently achieved by changing the conditions, and for the direct peroxide depolymerization method, the uncertainty of changing the post-cow reaction product deviation from the expected result is more serious (the obtained dFG) The difference between the amount and the target molecular weight can reach 5% or more).
本发明方法显著改善 dFG制备的重复性和可控性, 可能与催化剂所致活化能降 而形^目对稳定的 速率有关, 也可能与 温度降^ 时程缩短等温 和 牛及其 ^牛的可控性 ^N定性改善有关。  The method of the invention significantly improves the repeatability and controllability of the preparation of dFG, which may be related to the activation energy of the catalyst and the steady rate of the shape, and may also shorten the temperature and the time course to shorten the isothermal bovine and its cattle. Controllability is related to qualitative improvement.
对于相对纯净、 均一的 ^"制 FG原料而言, 相同反应条件下, 本发明方法所得 产物具有高度的重复性; 但对于含有较多杂质成分的含 FG "粗多糖"而言, 解聚反 应的稳定性与可控性仍有可^^在较大差异。 本发明人现已发现, 反应体系中存在 一定离子强度的 有机盐可以提高解¾½的稳定性。  For a relatively pure, homogeneous FG feedstock, the product obtained by the process of the invention has a high degree of repeatability under the same reaction conditions; however, for the FG "crude polysaccharide" containing more impurity components, the depolymerization reaction The stability and controllability of the present invention are still quite different. The present inventors have now found that the presence of an organic salt having a certain ionic strength in the reaction system can improve the stability of the solution.
为此, 本发明 一步提供提高和改善 FG解¾ ^可控性的方法, 即, 向金 属离子催化的 ^ 解^藻糖^ ^唐胺聚糖的 体系中加入一定浓度的^ ^/ 或有机盐。 所 i^bM^/或有机盐包括金属元素(如碱金属、 ¾i金属元素等)与卤 素、 有机酸等形成的盐, 有机酸或无机酸与有机碱形成的盐, 以及它们相互组合的 复合盐, 其中伏逃氯化钠、 氯化钟、 乙酸钠、 三水合乙酸钠、 乙酸钟。 本发明方法 中, 用于改善解聚 和反应可控性的无才 或有机盐的伏 的盐离子浓度为 约 O.l mmol/L至约 1.0mol/L。 盐离子改善^ J^H牛的机制不能完全阐明, 对于本发 明方法而言, 可能与其稳定反应物 FG的构象有关。  To this end, the present invention provides a method for improving and improving the controllability of FG solution, that is, adding a certain concentration of ^^/ or organic to a metal ion-catalyzed system of lyophilized polysaccharides. salt. The i^bM^/ or organic salt includes a salt formed of a metal element (such as an alkali metal, a metal element, etc.) with a halogen, an organic acid, or the like, a salt of an organic or inorganic acid and an organic base, and a combination thereof. Salt, which evades sodium chloride, chlorinated clock, sodium acetate, sodium acetate trihydrate, acetic acid clock. In the method of the present invention, the salt ion concentration of the valence or organic salt used for improving the depolymerization and the controllability of the reaction is from about 0.1 mmol/L to about 1.0 mol/L. The mechanism by which salt ions improve the J^H cattle cannot be fully elucidated. For the method of the present invention, it may be related to the conformation of the stable reactant FG.
本发明所述 FG是来源于棘皮动物海参纲的岩藻糖^ t胺聚糖, 其结构特征是 存在约 1: 1 ± 0.3摩尔比的 GlcUA和 GalNAc (^^_酯)以及不同摩尔比的岩藻糖(硫 酸酯)。 海参品种及其组织来源不同或提取方法的差异可导致 FG的单糖 比例、 胜存在形式以及多糖硫酸^ ί呈度等方面的不同, 但这些差异均不涉及 FG结构特 糖苷键类型的本质变化, 因此不影响本发明所述解聚方法的实 应用。 本发 明所述 FG的来源动物可选自但不局限于刺参、 绿刺参、 玉足海参、 黑海参、 黑乳 海参、 参等。 显然, 本领域技术人员可以理解, 对于产于世^^地的其它品种 海参, 其来源的符合上述结构特征的岩藻糖化糖胺聚糖均可以采用本发明所述方法 解聚以获得所需的低聚 FG产物, 因此, 本发明方法不受特定海参品种的限制。 The FG of the present invention is a fucose t-aminoglycan derived from the echinoderms of the echinoderms, which is characterized by the presence of GlcUA and GalNAc (^^-ester) in a molar ratio of about 1:1 ± 0.3 and different molar ratios. Fucose Acid ester). Differences in sea cucumber varieties and their tissue sources or differences in extraction methods may lead to differences in the ratio of monosaccharides, the forms of existence, and the degree of sulfate in the polysaccharides of FG, but these differences do not involve the essential changes in the type of FG structural polyglycoside bonds. Therefore, the practical application of the depolymerization method of the present invention is not affected. The source animal of the FG of the present invention may be selected from, but not limited to, sea cucumber, green sea cucumber, sea cucumber, black sea cucumber, black sea cucumber, and ginseng. Obviously, it will be understood by those skilled in the art that for other varieties of sea cucumbers produced in the world, the fucosylated glycosaminoglycans of the above-mentioned structural features can be depolymerized by the method of the present invention to obtain the desired The oligomeric FG product, therefore, is not limited by the particular sea cucumber variety.
本发明所得 dFG产物的还原' 端可通过 NMR法检测。 NMR检测还可以方便 地用于确认产物中 Fuc/GaJNAc组成比例。  The reduced end of the dFG product obtained in the present invention can be detected by NMR. NMR detection can also be conveniently used to confirm the Fuc/GaJNAc composition ratio in the product.
比较直接 i¾化物解聚与催化 化物解聚产物, 本发明发现, Mh 解聚法具有出人意料的糖 ^t i^选棒^其突出表 所得 dFG 上以 GalNAc 为还原 端(以末端数量计" "^在 80%乃至 95%以上)而较少为 GlcUA, 此与直 接 解聚产物存 目对高 ^f:的 性 GlcUA末端有^ ^差别,表明催化过 氧化物解聚法所得 dFG具有更好的末端均一性, 因而具有更好的质量均一性和可控
Figure imgf000006_0001
Comparing the direct i3⁄4 compound depolymerization with the catalytic compound depolymerization product, the present inventors have found that the Mh depolymerization method has an unexpected sugar ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ It is less than 80% or more than 95%) and less than GlcUA, which is different from the direct depolymerization product in the high GfUA end of the GfUA, indicating that the dFG obtained by the catalytic peroxide depolymerization method is better. End uniformity, thus better quality uniformity and controllability
Figure imgf000006_0001
Fuc GalNAc组成比例没有明显变化; 而直接过氧^勿解聚过程中, 该比例可存在约 5%左右的 氐, 一步证明本发明方法具有 的糖^ 的选择 。 There is no significant change in the composition ratio of Fuc GalNAc; in the direct peroxygen do not depolymerization process, the ratio may have about 5% enthalpy, which proves the choice of the sugar of the method of the present invention.
由此,本发明的又一目的是提^ "种低聚 FG(dFG), 所述 dFG通过本发明方法 制备, 于, 所述 dFG的 , 端主要为 GalNAc, 通过核磁共振(NMR) 技术 则可确认其组成比例不低于 80%, 相应地, 所述 dFG中, 以 GlcUA作为还 原 'f妹端的聚糖^ "数少于 20%。 的本发明 dFG中, 以 GalNAc为 4妹端 的多糖 数不少于 90%。  Therefore, another object of the present invention is to provide an oligomeric FG (dFG) prepared by the method of the present invention, wherein the dFG has a terminal mainly of GalNAc and is subjected to nuclear magnetic resonance (NMR) technology. It can be confirmed that the composition ratio thereof is not less than 80%, and accordingly, in the dFG, the number of glycans in which GlcUA is used as the reduction 'f sister' is less than 20%. In the dFG of the present invention, the number of polysaccharides having GalNAc as 4 sisters is not less than 90%.
dFG产物的 ^^量可采用高效劍交色谱法^ r测。 从保留 FG jk¾学活性以 ½ 免诱导血小板聚集活性考虑, 以重均^^量计, 本发明选 ^ £^0的 ^^量范围为 约 6,000 ~ 20,000Da, 伏逃分子量范围为约 10,000 ~ 15,000Da。 The amount of dFG product can be measured by high-efficiency sword-cross chromatography. Reserved FG jk¾ from active learning in ½-induced platelet aggregation activity Free considerations, weight average ^^ meter, the present invention is selected from ^ £ ^ ^^ 0 in an amount ranging from about 6,000 ~ 20,000Da, V escape molecular weight ranging from about 10,000 to 15,000 Da.
本发明所述 dFG的多^ t指数(PDI,重均分子量与数均分子量之比, Mw/Mn ) ~·*Η· 1.0至 2.0之间; 对于仂 的低聚 FG, 其 PDI介于 1.2至 1.6之间。  The multi-dimensional index (PDI, ratio of weight average molecular weight to number average molecular weight, Mw/Mn) of the dFG of the present invention is between 1.0 and 2.0; for the oligomeric FG of bismuth, the PDI is 1.2. Between 1.6.
本发明所述 dFG可以是其药学上可接受的碱金属、 金属等的盐,例如钠盐、 钾盐和钙盐等; 类^ U也, 本发明所述低聚 FG也可以是其药学上可接受的碱性有机 基团的酯。  The dFG of the present invention may be a salt of a pharmaceutically acceptable alkali metal, a metal or the like, such as a sodium salt, a potassium salt and a calcium salt; and the like, and the oligomeric FG of the present invention may also be a pharmaceutical thereof. An acceptable ester of an alkaline organic group.
本发明所述 dFG具有确切的^ L活性, 因此具有明确的药用潜力。 dFG具有 良好的水溶^, 因此易于制备成溶液型制剂或其冻干制品。 作为多糖类成分, 其口 月!^物利用有限, 因 制备成胃肠夕卜给药剂型, 其制剂制备可以按照本领域内 熟知的技术方法进行。 The dFG of the present invention has an exact activity and thus has a clear pharmaceutical potential. dFG has a good water solubility and is therefore easy to prepare into a solution preparation or a lyophilized product thereof. As a polysaccharide ingredient, its mouth! The use of the material is limited, due to the preparation of the gastrointestinal preparation dosage form, the preparation of the preparation can be in accordance with the field Well-known technical methods are carried out.
本发明的又一目的是提供一种药用组合物, 所述药用组合物包括本发明所述 dFG以及药学上可½的辅料。 本发明所述 dFG具有一定强度的^^活性, 因此可 以用于不同程度的 i^f生疾病的预防和治疗, 例如 J I^成性心血管疾病、 脑血管病, 肺静脉 全、 周围静脉 _ώ^、 深静脉 全、 周围性动脉 JW全等。 据此, 本发明可提供所^且^/在治疗 防心血管疾病的药物制备中的应用。 附图说明  A further object of the present invention is to provide a pharmaceutical composition comprising the dFG of the present invention and a pharmaceutically acceptable excipient. The dFG of the present invention has a certain intensity of activity, and thus can be used for the prevention and treatment of different degrees of i=f diseases, such as JI^ creative cardiovascular disease, cerebrovascular disease, pulmonary veins, peripheral veins ώ ^, deep veins, peripheral arteries JW congruent. Accordingly, the present invention can provide use in the preparation of a medicament for the treatment of cardiovascular diseases. DRAWINGS
图 1为刺参 FG及其降解产物 dFG的 HPGPC图谱;  Figure 1 shows the HPGPC spectrum of FG and its degradation product dFG;
图 2为显示 FG、 dFG中 Fuc/GalNA摩尔比(曱基信号积分面积比)的1 HNMR 谱图; 2 is a 1 H NMR spectrum showing a Fuc/GalNA molar ratio (integral area ratio of a thiol signal) in FG and dFG;
图 3A为 dFG-2的 ^-1!! COSY谱图; Figure 3A is a ^- 1 !! COSY spectrum of dFG-2;
图 3B为图 3 A 5.22ppm处的 COSY谱图截面,显示还原 端 GalNAc和 GlcUA 之 α-Η的 NMR信号。  Figure 3B is a cross-section of the COSY spectrum at 5.22 ppm of Figure 3A showing the NMR signals of the α-Η of the reducing ends GalNAc and GlcUA.
^^实 式 ^^ Reality
以下实施例用于进一步说明本发明 , 并不构成对 ^发明范围的限制。  The following examples are intended to further illustrate the invention and are not to be construed as limiting the scope of the invention.
实施例 1 金属离子催化的 FG的t ^解聚 Example 1 Metal ion catalyzed t ^ depolymerization of FG
1.1材料: 1.1 Materials:
FG: 刺参来源的岩藻 4唐^^唐胺聚糖, 按文! ^法(J Biol Chem, 1991, 266 (21): FG: Fucoid-derived rock algae 4 Tang ^^ Tang glycosaminoglycan, according to the text! ^ Method (J Biol Chem, 1991, 266 (21):
13530 ·6)提取制备。 纯度 98%(HPGPC,面积归一化法), ^"量(Mw), 69800。 13530 · 6) Extraction preparation. Purity 98% (HPGPC, area normalization), ^"mount (Mw), 69800.
H202, CH3COONa-3H20, NaCl, NaOH, CuCl2, FeCl2, ZnCl2等所用试剂: 均 为市售分析纯试剂。 Reagents for H 2 0 2 , CH 3 COONa-3H 2 0, NaCl, NaOH, CuCl 2 , FeCl 2 , ZnCl 2 , etc.: All are commercially available analytical reagents.
1.2方法: 1.2 method:
将四份刺参 FG各 5.0g溶解于圓 尧瓶内的 180ml水中, 45°C水浴保温并持续 均匀餅, 分别加入 10ml纯水或 20mmol/L浓度的氯 同 (Cu2+ )溶液、 氯化亚铁 (Fe2+ )溶:^氯化锌(Zn2+ )溶 ,在 2小时内,以 15 ml/h速率滴加 10%的 ¾(¾, 过程中用 1N的 NaOH溶液控制 pH值范围为 7.2 ~ 7.8, 上述 ^牛下连续 半反 应 2 ~ 8小时。 分别于 开始后 30min、 lh、 2h、 6h、 8h从各^ I»i 5ml, 加 入 15mg EDTA二钠盐并混匀 ,冰 7j ^P,加 3 、的 95%乙醇^定多糖, 5ml 60% 乙醇洗涤两遍, 热空气吹干乙醇, 10ml纯水定容, 高效 交色谱(HPGPC )法检测 产物分子量。 Dissolve 5.0g of each of the four sea cucumbers FG in 180ml water in a round bottle, keep warm in a 45 °C water bath and continue to evenly cake, add 10ml pure water or 20mmol/L concentration of chlorine (Cu 2+ ) solution, chlorine Ferrous (Fe 2+ ) solution: ^Zinc chloride (Zn 2+ ) dissolved, 10% 3⁄4 (3⁄4) was added at a rate of 15 ml/h within 2 hours. The pH was controlled with 1N NaOH solution during the process. The value ranged from 7.2 to 7.8, and the above half-reaction was carried out for 2 to 8 hours. At the 30 min, lh, 2 h, 6 h, and 8 h after the start, 15 mg of EDTA disodium salt was added from each ^ I»i 5 ml, and mixed. Ice 7j ^ P, add 3, 95% ethanol to determine the polysaccharide, 5ml 60% ethanol washed twice, hot air blow dry ethanol, 10ml pure water to volume, high performance cross-chromatography (HPGPC) method to determine the molecular weight of the product.
1 结果: 1 result:
在有无第四周期过渡金属离子催化剂存在下, 过氧化氢对刺参 FG的解聚 « 见表 1和附图 1。 表 1: FG 化解聚产物 测 Depolymerization of hydrogen peroxide to sea cucumber FG in the presence or absence of a fourth periodic transition metal ion catalyst is shown in Table 1 and Figure 1. Table 1: FG depolymerization product measurement
不同时间点的解聚产物分子量 (Da)  Depolymerization product molecular weight at different time points (Da)
 ,
Omin 30min 60min 120 min 360 min 480 min  Omin 30min 60min 120 min 360 min 480 min
¾(¾+纯水 69,800 60,500 58,700 54,100 48,030 41,010 3⁄4 (3⁄4+ pure water 69,800 60,500 58,700 54,100 48,030 41,010
HiOz + Cu2" 69,800 33,906 21,952 14,996 12,450 8,805HiOz + Cu 2 " 69,800 33,906 21,952 14,996 12,450 8,805
H2(¾+Fe2+ 69,800 343)0 26,700 19,854 16,906 12,400H 2 (3⁄4+Fe 2+ 69,800 343)0 26,700 19,854 16,906 12,400
H2(¾+Zn2+ 69,800 32,805 27,903 18,031 15,762 11,080 表 1的结^ 明, 金属离子 Cu2+、 Fe2+、 Zn2+对 FG的 ^^解¾½«" 有明显的催化作用, 解聚 速率显著提升。 通过比较这三种催化剂的催化效率可 以看出,金属离子 Cu2+的催化作用效率较高,其^^ ^豆的时间内实现 dFG的制备。 实施例 2直接过氧化物解聚法与金属离子催化过氧化物解聚法所得 dFG产物的 NMR图潘检测 H 2 (3⁄4+Zn 2+ 69,800 32,805 27,903 18,031 15,762 11,080) The results of Table 1 show that the metal ions Cu 2+ , Fe 2+ , Zn 2+ have a significant catalytic effect on the F ^ ^ ^ 3⁄41⁄2 « " The polymerization rate is significantly improved. By comparing the catalytic efficiencies of the three catalysts, it can be seen that the catalytic efficiency of the metal ion Cu 2+ is high, and the preparation of dFG is realized in the time of the bean. NMR Spectroscopic Detection of dFG Products Obtained by Depolymerization and Metal Ion Catalytic Peroxide Depolymerization
2.1材料: 2.1 Materials:
FG: 刺参来源的岩藻糖^ ^唐胺聚糖, 按文^ "法(J Biol Chem, 1991, 266 (21): 13530-6)提取制备。 纯度 98%(HPGPC,面积归一化法), 量 (Mw), 69800。  FG: Fucose-derived fucose ^ ^-glycan, prepared by the method "J Biol Chem, 1991, 266 (21): 13530-6). Purity 98% (HPGPC, area normalization) Method), quantity (Mw), 69800.
H2O2, CH3COONa-3H20, NaCl, NaOH, Cu(CH3COO ¾0等所用试剂: 均为 市售分析纯试剂。 H2O2, CH 3 COONa-3H 2 0, NaCl, NaOH, Cu (CH3COO 3⁄40, etc. Reagents used: All are commercially available analytical reagents.
2.2方法: 2.2 Method:
制备 dFG: 将两份刺参 FG各 5.0g溶解于圓 瓦内的 180ml 7j溶液中, 分别 以 70。C和 35。C水浴保温并持续均匀搅拌,然后分别加入 10ml纯水或 60 mmol/L浓 度的乙酸铜 (Cu2 )溶液,继而在 2小时内以 lOml/h速率滴加 10%的 ¾(¾,反应过程 中用 1N的 NaOH溶液控制 pH值范围为 7.2 ~ 7.8。 上述^ ί牛下连续観半 4小时 后,分别向 液中加入 500 mg EDTA二钠盐并混匀,冰 τ ^Ρ,加 3 只的 95。/。 乙醇^定多糖, 离心得; ; 定, 100ml 60%乙醇洗潦两遍, 离心得 H。 ;^定溶解于 150ml水中, 经 001x7型阳离子树脂交 4械钠盐, 然后以截留^ "量 3500Da的透析 膜透析 ό小时, 截留产物 , 冷冻干燥, 分别得到 3.23g (dFG-l,直接 ¾(¾解聚 产物)和 3.52 g (dFG-2, Cu2+催化的 ¾(¾解聚产物)解聚样品。 Preparation of dFG: 5.0 g of each of the two sea cucumbers FG was dissolved in a 180 ml 7j solution in a round tile, respectively, to 70. C and 35. C water bath insulation and continuous uniform stirring, then add 10ml pure water or 60mmol / L concentration of copper acetate (Cu 2 ) solution, then add 10% 3⁄4 at a rate of 10ml / h within 2 hours (3⁄4, the reaction process The pH range was controlled from 1N NaOH solution to 7.2 ~ 7.8. After the continuous simmering for 4 hours, add 500 mg EDTA disodium salt to the solution and mix well, ice τ ^ Ρ, add 3 95% ethanol, centrifuged;; fixed, 100ml 60% ethanol wash twice, centrifuged to obtain H.; dissolved in 150ml water, 001x7 type cationic resin, 4 sodium salt, then Interception ^ "3500Da dialysis membrane dialysis ό hour, the product was intercepted, lyophilized, respectively, to obtain 3.23g (dFG-l, direct 3⁄4 (3⁄4 depolymerization product) and 3.52 g (dFG-2, Cu 2+ catalyzed 3⁄4 ( 3⁄4 depolymerization product) depolymerized sample.
理^^ ί则: HPGPC ^i则^1量及分布; 电导法检测 -OSC ACOa摩尔比。 ^^ ί: HPGPC ^i ^ 1 amount and distribution; Conductivity detection - OSC ACOa molar ratio.
NMR^i则:  NMR^i:
仪器, AVANCEAV400超导核磁共振 [义(瑞士 Bruker公司 400MHz);  Instrument, AVANCEAV400 superconducting nuclear magnetic resonance [Yi (Swiss Bruker 400MHz);
溶剂, I¾099.9Atom%D (Norell公司);  Solvent, I3⁄4099.9Atom%D (Norell);
内标, trimethylsilyl-propionic acid (TSP-D4 ); 温度, 45 °C。  Internal standard, trimethylsilyl-propionic acid (TSP-D4); temperature, 45 °C.
2.3结果 检测结果见下表 2。 NMR谱图见附图 2。 2.3 Results The test results are shown in Table 2 below. The NMR spectrum is shown in Figure 2.
表 2: FG、 (^0-1及^0-2的理^^测与>^1 ^^则 Table 2: FG, (^0-1 and ^0-2, ^^^^^^^^
NMR检测  NMR detection
才 口口 Only mouth
Mw n GalNAc(CH3) Ga Ac/ Mw n GalNAc(CH 3 ) Ga Ac/
PDI -OS(¾7-COO- (Da) (Da) /Fuc(CH3) GlcUA* PDI -OS(3⁄47-COO- (Da) (Da) /Fuc(CH 3 ) GlcUA*
FG 68,740 63,468 1.08 3.46 1: 1.02 - dFG-1 18,960 11,760 1.61 3.32 1: 0.93 1:0.45 dFG-2 14,930 10,660 1.40 3.45 1:1.00 1:0.08 FG 68,740 63,468 1.08 3.46 1: 1.02 - dFG-1 18,960 11,760 1.61 3.32 1: 0.93 1:0.45 dFG-2 14,930 10,660 1.40 3.45 1:1.00 1:0.08
Mw: 重均^ ^量; Mn: 数均 量; PDI: 量多 指数(PDI=Mw/Mn) Mw: weight average ^ ^ quantity; Mn: number average; PDI: quantity multi-index (PDI=Mw/Mn)
* ι^ ¾糖 尔比 通过 1^ 矣 化 聚、催化 i± 匕 聚的^ ^糾 (70°C/4h, 35°C/4 h)以及两种反应产物的分子量(约 1.9kDa和约 1.5 kDa)可以看出, 在 Cu2+离子存 在下, (¾解聚 FG的反应温度^氏, 效率更高。 * ι^ 3⁄4 sugar ratio by 1 ^ 矣 poly, catalyzed i ± 匕 ^ ^ ^ (70 ° C / 4h, 35 ° C / 4 h) and the molecular weight of the two reaction products (about 1.9kDa and about 1.5 kDa) It can be seen that in the presence of Cu 2+ ions, (3⁄4 depolymerization FG reaction temperature is higher, the efficiency is higher.
从两种产物的理化及波谱分析结果可见, dFG-1和 dFG-2的 PDI值均较 FG有 所升高,此与粘多糖的 4 自由 聚特 目符, 而 dFG-2的練 ^目对较低。  From the physicochemical and spectral analysis results of the two products, it can be seen that the PDI values of dFG-1 and dFG-2 are higher than those of FG, which is related to the 4 free polyhime of mucopolysaccharide, and the practice of dFG-2. Right lower.
从 -OSC ACOa比^ f, dFG-1的值与 FG 4目比 4%,而 dFG-2 无变 化。  From -OSC ACOa ratio ^f, the value of dFG-1 is 4% to FG 4 mesh, while dFG-2 is unchanged.
根据 NMR甲基信号积^十算的 GalNAcFuc摩尔比(岩藻糖曱基峰信号出 ί½ 约 1.3 ppm, 而乙¾^半 1唐的曱基峰位于约 2.1 ppm )可见, dFG-1较 FG 氐约 9%, 而 dFG-2 无变化。 该结^ ^明, 在 Cu2+离子存在下, Η2(¾解聚 FG的过 考 岩藻糖 乎无影响。 显然, 根据直接±^t^解^斤得 dFG-1的 Fuc比例 变化可以判断, 直接 化解聚可导 ¾ ^藻糖«酯 胜»。 According to the NMR methyl signal product, the GalNAcFuc molar ratio (the fucose sulfhydryl peak signal is about 1.3 ppm, and the 33⁄4^ 1/2 tang 曱 base peak is about 2.1 ppm), dFG-1 is more FG. About 9%, while dFG-2 did not change. In the presence of Cu 2+ ions, Η 2 (3⁄4 depolymerized FG has no effect on the fucoids. Obviously, according to the direct ±^t^ solution, the Fuc ratio of dFG-1 is changed. It can be judged that the direct depolymerization can lead to the formation of "alcohol".
从附图 3A可以判断解聚产物 端的 GalNAc及 GlcUA的摩尔比, 其中 非还原 端以及多糖主链中的 GalNAc及 GlcUA的桥头氢均为 β~构型, 其 NMR 信号出现约 4.4 ~4.6 ppm之间, 而 ' 端 GaJNAc及 GlcUA各存在约半数的 α- 构型桥头氢。 lH NMR谱图中 GalNAc及 GlcUA的 α-构型桥头氢均出 ί½约 5.2 ~ 5.3 ppm, 两者难以区分,但与它们相关的 H2#^J化学^ ^多分别出现约 4.2 ~ 4.5 ppm和 3.6 ~3.9 ppm, 因此可以 目关 " 普图中予以区分(原型 FG因^ "量较大, 末端糖 基数较少而难以获得足够强的区分信号 )。 From Fig. 3A, the molar ratio of GalNAc and GlcUA at the depolymerization product end can be judged, wherein the non-reducing end and the bridgehead hydrogen of GalNAc and GlcUA in the polysaccharide main chain are both β-configuration, and the NMR signal appears to be about 4.4 to 4.6 ppm. Meanwhile, the 'ends of GaJNAc and GlcUA each have about half of the α-configuration bridgehead hydrogen. In the H NMR spectrum, the α-configuration bridgehead hydrogen of GalNAc and GlcUA is about 5.2 ~ 5.3 ppm, which is difficult to distinguish between them, but the H2#^J chemistry associated with them is about 4.2 ~ 4.5 ppm. And 3.6 ~ 3.9 ppm, so it can be seen in the "PuD" to distinguish (the prototype FG due to ^" large amount, the number of terminal glycosyl groups is small and it is difficult to obtain a sufficiently strong distinguishing signal).
从附图 3B推算可知,在 dGAG-1和 dGAG-2的 ' 端上的 GalNAc与 GlcUA 的摩尔比分别为约 1: 0.45和约 1: 0.08,由此可见, Cu2+催化的¾化 聚法对 FG 中的 GalNAc β (1→4)糖 具有^; 的选择i。 It can be seen from Fig. 3B that the molar ratios of GalNAc to GlcUA at the 'ends of dGAG-1 and dGAG-2 are about 1:0.45 and about 1:0.08, respectively, which shows that the Cu 2+ catalyzed 3⁄4 polymerization method For FG The GalNAc β (1→4) sugar has the choice i of ^;
本发明的研究结 明, 金属离子催化可以显著提高 it^t^解聚法对糖苦鍵 的选棒 f生。尽管有 ¾iiCu2+离子催^ ^ t 的 勿解聚过程中^示出一定的 选择 f生, ^"确切机制不明。 根据解¾½机制判断, 本发明之催化解¾½的选 生应与催化剂对自由基 不同类型糖^ ^的活化能的影响有所差异有关。 The research of the present invention shows that the metal ion catalysis can significantly improve the selection of the sugar bit bond by the it^t^ depolymerization method. In spite of the fact that there is a 3⁄4iiCu 2+ ion catalyzed ^ ^ t in the process of depolymerization, a certain choice of f is shown, ^ "the exact mechanism is unknown. According to the mechanism of the solution, the selection of the catalytic solution of the present invention should be matched with the catalyst. The effects of activation energy of free radicals of different types of sugars ^ ^ are related.
本发明的研究结果½i¾, 对于 FG的金属离子催化的过氧化物解聚法, dFG 产物中以 GalNAc为还原 端的聚糖分子数通常可达 80%以上, 而本实施例中, 以 GalNAc为 '1¾端的比例已 95%。 实施例 3直接± 解聚法与金属离子催化 ijA化物解聚法制备的 dFG的重复性 和可控性比较  The results of the present invention are 1⁄2i3⁄4. For the metal ion-catalyzed peroxide depolymerization method of FG, the number of glycan molecules with GalNAc as the reducing end in the dFG product is usually more than 80%, and in this embodiment, GalNAc is used as ' The ratio of the 13⁄4 end is 95%. Example 3 Comparison of repeatability and controllability of dFG prepared by direct ± depolymerization and metal ion catalysis ijA depolymerization
3.1材料: 3.1 Materials:
同 2.1  Same as 2.1
3.2方法: 3.2 Method:
直接 化氢法解聚 F& 五份刺参 FG各 300g溶解于 9L水中, 60°C水浴保 温并持续均匀 半,继而在 2小时内以 0.6L/h速率滴加 15%的 (¾, 过程中用 1 N的 NaOH溶液控制 pH值范围为 7.2 ~ 7.8。 该 ^牛下连续 半^ ^ 6.5小时后, 分别向 液中加入 3.0g EDTA二钠盐并混匀, 冰 加 3 ^、的 95%乙醇 '; 定多糖, 离心得、; J定, 用 0.6L60%乙醇洗涤两遍, 然后溶于 10L水中以截留 量 3000Da的改良纤维素 ¾滤、 6小时,截留产物 ,冷冻干燥,计算产物得率并 检测产物 量及其分布。  Direct hydrogen process depolymerization F & five parts of sea cucumber FG each 300g dissolved in 9L water, 60 ° C water bath insulation and continuous uniform half, then in a 2 hour at a rate of 0.6L / h drop 15% (3⁄4, in the process Use 1 N NaOH solution to control the pH range from 7.2 to 7.8. After 6.5 hours of continuous treatment, add 3.0 g of EDTA disodium salt to the solution and mix well. Add ice to 3 ^, 95%. Ethanol'; fixed polysaccharide, centrifuged; J, washed twice with 0.6L of 60% ethanol, then dissolved in 10L of water with a cut-off of 3000Da modified cellulose 3⁄4 filter, 6 hours, cut off the product, freeze-dried, calculate the product Rate and detect the amount of product and its distribution.
Cu2+催化的过氧化氢法解聚 FG:五份刺参 FG各 300g溶解于 9L水中, 45。C水 浴保温并持续均匀 4 半, 然后分别加入 0.6L纯水或 20mmol/L浓度的乙酸铜 ( Cu2+ ) 溶液, 继而在 2小时内以 0.6L/h速率滴加 15%的 H202, ^^过程中用 1 N的 NaOH 溶液控制 pH值范围为 7.2 ~ 7.8。 该^ (牛下连续 4 半 4小时后, 分别向 液中 加入 3.0g EDTA二钠盐并混匀, 冰 7j Hp, 加 3 ^^P、的 95%乙醇; ¾ί定多糖, 离心 得沉淀, 用 0.6L 60%乙醇洗涤两遍, 然后溶于 10L水中以截留分子量 3000Da的改 良纤维素舰滤 6小时, 截留产物 , 冷冻干燥, 计算产物得率并检测产物^" 量及其分布。 Cu 2+ catalyzed dehydrogenation of FG by hydrogen peroxide: 300 g of each of the five sea cucumbers FG was dissolved in 9 L of water, 45. C water bath insulation and continuous uniformity of 4 and a half, then add 0.6L pure water or 20mmol / L concentration of copper acetate (Cu 2+ ) solution, and then add 15% H 2 0 at a rate of 0.6L / h within 2 hours 2 , ^^ process with 1 N NaOH solution to control the pH range of 7.2 ~ 7.8. After 4 hours and 4 hours in a row, 3.0 g of EDTA disodium salt was added to the liquid and mixed, ice 7j Hp, 3 ^^P, 95% ethanol; 3⁄4 定定 polysaccharide, centrifuged to precipitate, It was washed twice with 0.6 L of 60% ethanol, then dissolved in 10 L of water to filter the modified cellulose ball with a molecular weight of 3000 Da for 6 hours, the product was withdrawn, freeze-dried, the yield of the product was calculated, and the amount and distribution of the product were measured.
3.3结果 3.3 Results
结果 3。 表 3: 直接过氧化氢解聚 FG及 (^2+催化 化氢解聚 FG的产物 Result 3. Table 3: Direct hydrogen peroxide depolymerization FG and (^ 2+ catalytic hydrogen depolymerization FG products
解!^法 产物 Mw (Da) Mn (Da) PDI  Solution!^ Method Product Mw (Da) Mn (Da) PDI
1 17,360 10200 1.70  1 17,360 10200 1.70
2 19,320 12350 1.56 直接 3 18,690 13,100 1.43  2 19,320 12350 1.56 Direct 3 18,690 13,100 1.43
化嬉聚 4 16,780 11,560 1.45  Fooling together 4 16,780 11,560 1.45
5 16,820 9,980 1.69  5 16,820 9,980 1.69
RSD(%) 6.47 11.78 8.16  RSD (%) 6.47 11.78 8.16
1 10,500 8,040 1.31  1 10,500 8,040 1.31
2 11,020 8,760 1.26  2 11,020 8,760 1.26
Cu2+催化 Cu 2+ catalysis
3 10,780 7,900 1.36  3 10,780 7,900 1.36
的 化  Turn
娜聚 4 10,660 7,890 1.35  Na Ju 4 10,660 7,890 1.35
5 11340 8,030 1.41  5 11340 8,030 1.41
RSD(%) 3.03 4.46 4.20  RSD (%) 3.03 4.46 4.20
Mw: 重均 量, Mn: 数均^ ^量, PDI: 量多^ L指数(PDI = Mw/Mn)  Mw: weight average, Mn: number average ^ ^ quantity, PDI: quantity more ^ L index (PDI = Mw / Mn)
RSD: 相对标准偏差  RSD: relative standard deviation
表 3的结果显示, 直接 化 ¾^斤得 dFG产物^ "量批间差异较大, 其重 均分子量和数均分子量的 RSD值均大于 5%; 而催化 化氢解聚所得产物^ ^量 批间差异较小, 其重均 量和数均^ "量的 RSD值均小于 5 %。 而且, 直接± L 化氢解聚所得产物 Mw、 Mn、 PDI三项检测值的 RSD均明显大于根据本发明的方法 所得的产物, 表明本发明的催化过氧化氢解聚法有更好的稳定性和可控性。 实施例 4 ^度金属离子催化¾化物法解聚玉 参粗多糖  The results in Table 3 show that the direct D3G product has a large difference between the batches, and the RSD values of the weight average molecular weight and the number average molecular weight are both greater than 5%; and the product obtained by catalytic hydrogen depolymerization The difference between batches is small, and the RSD values of both the weight average and the number average are less than 5%. Moreover, the RSD of the three detection values of the products Mw, Mn, and PDI obtained by directly dehydrating the hydrogen is significantly larger than that obtained by the method of the present invention, indicating that the catalytic hydrogen peroxide depolymerization method of the present invention is more stable. Sex and controllability. Example 4 ^3 metal ion catalyzed 3⁄4 compound method to dissolve jade ginseng crude polysaccharide
4.1材料: 4.1 Materials:
玉 ^参: 市售品种  Jade ginseng: Commercial varieties
试剂: 同 2.1  Reagents: same as 2.1
4.2方法: 4.2 Method:
玉 ^参岩藻糖條胺斜綱唐的制备 (参考文 法制备 ):取干燥玉 参 1000g,粉碎, ^ 浴 器中, 加入 10L 浸泡。加入固体氢氧化钟至浓度 为 1N, 60°C恒温籍 100min。 冷却后, ό N盐酸调 pH值为 8.5, 加入 50g胰 蛋白酶, 50°C下保温 3小时。 后, 离心去 ϋ。 取上清液, 用盐酸调 节 pH值为 2.5, 离心去除酸性蛋白^定。 取上清液, 加 2N NaOH溶液中和, 离心 ^冗淀。 取上清液, 加 95 %乙醇使其浓度达 60%, 4。C 过夜。 离心得沉淀, 加 10倍重量的水 , 离心去除不 ¾4勿。 取上清液, 加醋酸钾» ^溶 4吏其最终浓度 为 2.0mol/L, 加 95 %乙醇至其最终 ^ ^ 为 30% , 静置沉淀。 离心得到的沉淀, 依次用 95 %乙醇、 无水乙醇洗涤, 减压真空干燥, 即得 4:¾参多糖 8.1 g。 Preparation of jade ginseng fucoidan sylvestris (refer to grammar preparation): Take dried jade ginseng 1000g, pulverize, ^ bath, add 10L soak. A solid hydrogenation clock was added to a concentration of 1 N, and the temperature was kept at 60 ° C for 100 min. After cooling, όN hydrochloric acid was adjusted to pH 8.5, 50 g of trypsin was added, and the mixture was incubated at 50 ° C for 3 hours. After that, centrifuge to remove the sputum. The supernatant was taken, and the pH was adjusted to 2.5 with hydrochloric acid, and the acidic protein was removed by centrifugation. Take the supernatant, neutralize with 2N NaOH solution, centrifuge ^ redundancy. Take the supernatant and add 95% ethanol to make the concentration reach 60%. C overnight. Centrifuge to obtain a precipitate, add 10 times the weight of water, and remove it by centrifugation. The supernatant was taken and potassium acetate was added to dissolve the mixture to a final concentration of 2.0 mol/L, and 95% ethanol was added until the final ^^ was 30%, and the precipitate was allowed to stand. The precipitate obtained by centrifugation was washed successively with 95% ethanol and absolute ethanol, and vacuum-dried under reduced pressure to obtain 8.1 g of 4:3⁄4 ginseng polysaccharide.
Cu2+催化的 化氢法解聚 FG:五份玉 参粗多糖各 5.0g溶解于圓;^尧瓶内 的 190ml水中, 35。C水浴 ί显并 ^均匀観半, 然后分别加入 50mmol/L浓度的乙 酸铜 (Cu2+)溶液 10ml, 继而以 lOml/h速率滴加 10 %的 H202,反应过程中用 1 N的 NaOH溶液控制 pH值范围为 7.2 ~ 7.8。 上述 ^牛下连续^ ^半^ 3小时后, 分别向 液中加入 500mg EDTA二钠盐并混匀, 冰 7j p, 加 3 的 95 %乙醇 ϋ 多糖, 离心得^定, 用 100ml 60%乙醇洗涤两遍, 100ml 7J溶后, 加醋酸钟観 溶使其最终浓 2.0mol/L,静置过夜, 离心收集;^定, 100ml水溶, 然后以截留分 子量 3500Da的透析膜透析 8小时,截留产物冷冻干燥,计算产物得率并检测产物分 子量及分布。 Cu 2+ catalyzed hydrogenation of FG: 5.0 g of crude polysaccharides of five parts of jade ginseng dissolved in a circle; 190 ml of water in a bottle, 35. C water bath ί 显 and ^ uniform halving, then add 50mmol / L concentration of copper acetate (Cu 2+ ) solution 10ml, then add 10% H 2 0 2 at a rate of 10ml / h, 1 N during the reaction The NaOH solution controls the pH range from 7.2 to 7.8. After the above ^ 2 cattle for 2 ^ 3 hours, add 500mg EDTA disodium salt to the liquid and mix, ice 7j p, add 3 of 95% ethanol ϋ polysaccharide, centrifuge to determine, with 100ml 60% ethanol Wash twice, 100ml 7J dissolved, add acetic acid clock to dissolve the final concentration of 2.0mol / L, stand overnight, collect by centrifugation; determine, 100ml water soluble, and then dialyzed for 8 hours with a molecular weight cut off of 3500Da dialysis membrane, the product is freeze-dried Calculate the yield of the product and measure the molecular weight and distribution of the product.
一定离子强度下的 Cu2+催化的 i l 匕氢法解聚 F&五份玉 参粗多糖各 5.0g 溶解于圓^ 瓦内含有 12.21g三水合乙酸钠和 6.02g氯 ! ¾的 190ml水中, 35。C水 浴保温并機均匀餅,然后分别加入 50mmol/L浓度的乙酸铜 ( Cu2+ )溶液 10ml, 继而以 lOml/h速率滴力口 10 %的 (¾, 过程中用 1N的 NaOH溶液控制 pH值范 围为 7.2 ~ 7.8。上述^ ί牛下连续4¾!半^ ^ 4小时后,分别向 液中加入 500mg EDTA 二钠盐并混匀,冰 τ ^Ρ,加 3 ^Μ?、的 95 %乙醇^ ^定多糖, 离心得 iKJ定, 100ml 60 %乙醇洗涤两遍, 100ml水溶后,加醋酸钾^^ ^溶使其最终浓度为 2.0mol/L,静置 过夜,离心收集^定, 100ml水溶,然后以截留^ 量 3500Da的透析膜透析 8小时, 截留产物冷冻干燥, 计算产物得率并 '浐物^ "量及分布。 Cu 2+ catalyzed by ionic cesium hydrogen depolymerization F & five parts of crude polysaccharides of jasper ginseng each 5.0g dissolved in round watts containing 12.21g of sodium acetate trihydrate and 6.02g of chlorine! 3⁄4 of 190ml of water, 35 . C water bath insulation and uniform cake, then add 50ml / L concentration of copper acetate (Cu 2+ ) solution 10ml, and then drop 10% at 10ml / h rate (3⁄4, process with 1N NaOH solution to control pH The value range is 7.2 ~ 7.8. After the above ^ ί cattle for 43⁄4! half ^ ^ 4 hours, add 500mg EDTA disodium salt to the liquid and mix well, ice τ ^ Ρ, add 3 ^ Μ?, 95% Ethanol ^ ^ polysaccharide, centrifuged to obtain iKJ, 100ml 60% ethanol washed twice, 100ml water soluble, add potassium acetate ^ ^ ^ dissolved to a final concentration of 2.0mol / L, left overnight, centrifuged to collect, 100ml The solution was lyophilized for 8 hours with a 3500 Da dialysis membrane, and the cut-off product was freeze-dried to calculate the product yield and the amount and distribution of the product.
4.3 结果 4.3 Results
结果 4。  Result 4.
表 4: 玉 ^参粗多糖的 化氢法解聚  Table 4: Dehydrogenation of crude polysaccharides from Jade
解¾ ^法 产物 4^欠 Mn (Da) PDI  Solution 3⁄4 ^ method product 4^ under Mn (Da) PDI
1 13,320 9,560 1.39  1, 13,320 9,560 1.39
2 11,090 8270 1.34  2 11,090 8270 1.34
Cu2+催化 3 9,790 7,120 1.38 Cu 2+ catalysis 3 9,790 7,120 1.38
匕氢  Hydrogen
解聚 4 12,800 9,430 1.36  Depolymerization 4 12,800 9,430 1.36
5 10,750 8,040 1.34  5 10,750 8,040 1.34
RSD (%) 12.70 12.01 0.84 1 11,690 8,660 1.35 RSD (%) 12.70 12.01 0.84 1, 11,690 8,660 1.35
1.0 M离子 2 11,720 8,450 1.39  1.0 M ion 2 11,720 8,450 1.39
强度下的  Under strength
Cu2+催化 3 12,030 9,030 1.33 Cu 2+ catalysis 3 12,030 9,030 1.33
化 10,940 8,140 1.34 聚  10,940 8,140 1.34
5 11,830 ¾530 1.38  5 11,830 3⁄4530 1.38
RSD(%) 3.60 3.79 1.91  RSD (%) 3.60 3.79 1.91
Mw: 重均^ "量, Mn: 数均^ ^量, PDI: ^^量多^ t指数 (PDI = Mw/Mn)  Mw: weight average ^ "quantity, Mn: number average ^ ^ quantity, PDI: ^ ^ quantity more ^ t index (PDI = Mw / Mn)
RSD: 相对标准偏差  RSD: relative standard deviation
表 4的结果显示, 对于粗多糖而言, 由于其杂质含量相对较高, 此时采用金属 离子催化的 化 聚, 其所得产物仍然可肯 在较大的批间差异, 其主要表现 在平均分子量存在明显差异(RSD>10% ), 而分散系 差异。  The results in Table 4 show that for crude polysaccharides, due to the relatively high impurity content, metal ion-catalyzed polymerization is used at this time, and the obtained product can still be subjected to large batch-to-batch variation, which is mainly manifested in average molecular weight. There is a significant difference (RSD > 10%), while the dispersion is different.
向反应介质中添加一定强度的无才 或有机离子, 可显著改善解聚反应的重复 性, 尽管添加这些离子可能^ J≥速率 ^一定程度的 氐。 ^或有机离子改 善反应重复性的机制尚未完全清楚, 认为可能与维持多糖稳定的构象有关。  Adding a certain intensity of non-organic or organic ions to the reaction medium can significantly improve the reproducibility of the depolymerization reaction, although the addition of these ions may be a certain degree of enthalpy. ^ or the mechanism by which organic ions improve the repeatability of the reaction is not fully understood and may be thought to be related to maintaining a stable conformation of the polysaccharide.
本发明的相关研究表明, 不同种属海参来源的非纯净 FG的±| 匕解聚反应中, 对于所 ii LW或有机离子, 适宜的阳离子强度约为 O.lmol/L至 1.0mol/L。 实施例 5低 藻糖^ ^唐胺聚糖 (dFG )的^ k活性  The related research of the present invention shows that in the ±| 匕 depolymerization reaction of the non-pure FG of different species of sea cucumber, the suitable cation strength is about 0.1 mol/L to 1.0 mol/L for the ii LW or organic ion. Example 5 ^ k activity of low saccharose ^ ^ teratamine (dFG)
5.1材料 5.1 material
系列玉 ^参 dFG: Mw分别为 25,380、 18,050、 14,350、 11,450、 8,800。按实 施例 4.中 Cu2+催化的解聚法制备(解聚时间不同); The series of jade ginseng dFG: Mw are 25,380, 18,050, 14,350, 11,450, 8,800 respectively. Prepared according to Cu 2+ catalyzed depolymerization method in Example 4. (dimerization time is different);
试剂: 兔贫血小^ 浆, 广州蕊特生物科技有限公司;  Reagents: rabbit anemia small ^ pulp, Guangzhou Rui Te Biotechnology Co., Ltd.;
活化部分凝血活酶时间 (ΑΡΤΓ )测定试剂盒(鞣花酸): 上海太阳生物技术有 限公司  Activated partial thromboplastin time (ΑΡΤΓ) assay kit (ellagic acid): Shanghai Sun Biotechnology Co., Ltd.
仪器: BICO双信 it r¾仪, Minivolt公司 (意大利)。  Instrument: BICO Double Letter it r3⁄4 instrument, Minivolt (Italy).
5.2方法 5.2 method
准确雜 ^ 羊品 13.0mg, 溶解定溶至 100ml, 然后稀針倍。 按试剂盒说明书 的方法测各样品的 ΑΡΤΓ时间, 扣除空白血浆的凝血时间, 即是样品延长凝血的时 间 ΔΑΡΤΤ ( Sec )。  Accurately miscellaneous ^ 1100mg of sheep, dissolved and dissolved to 100ml, then thin needle times. The time of each sample was measured according to the method of the kit, and the clotting time of the blank plasma was subtracted, which is the time ΔΑΡΤΤ (Sec) of the sample to prolong the blood coagulation.
5.3结果 5.3 Results
实 3^果如表 5所示。 表 5: 玉足海参来源的不同分子量的 dFG对家兔血浆 ΑΡΊΤ时间的影响 The actual 3^ fruit is shown in Table 5. Table 5: Effect of different molecular weight dFG derived from Jade foot sea cucumber on plasma sputum time in rabbits
dFG 量  dFG amount
25 80 18,050 14^50 11,450 8,800 (Mw )  25 80 18,050 14^50 11,450 8,800 (Mw )
AAPTT(Sec) 95.1 76.0 64.2 40.9 15.3 表 5中的结^^示, 玉 参来源的 dFG可以 延长 浆 ΑΡΤΓ时间, 表 明其能够抑制内源性¾1。 实施例 6低> ^藻糖化糖胺聚糖 (dFG )的冻干制品  AAPTT(Sec) 95.1 76.0 64.2 40.9 15.3 The results in Table 5 show that dFG derived from jade ginseng can prolong the pulping time, indicating that it can inhibit endogenous 3⁄41. Example 6 lyophilized product of low > ^ alginate glycosaminoglycan (dFG)
6.1材料 6.1 Materials
刺参 dFG: Mw 14,350。 按实施例 3中 Cu2+催化的解聚法制备。 Sea cucumber dFG: Mw 14,350. Prepared by the Cu 2+ -catalyzed depolymerization method in Example 3.
20mmol/LpH7.0磷酸緩沖液(PBS )  20mmol/L pH7.0 phosphate buffer (PBS)
6.2处方 6.2 prescription
Figure imgf000014_0001
Figure imgf000014_0001
6.3制备工艺  6.3 preparation process
称舉处方量的刺参 dFG 20mmol/L pH 7.0 PBS至全量, 解 完全。 加入 0.6%的药用活性炭, 半 20min; 布氏漏斗及 3.0μπι微孔滤舰炭 虑。 测中间体^ f:。合格后用 0.22μιη的微 lUi膜±虑; 灌装于管制西林瓶中,每 瓶 0.5ml, 灌装过程监测装量, 半压塞, 置冷冻干腐 g内, ^^的冻干曲线进行冻 干, 压塞, 出箱, 轧盖, 目 4佥合格, 得成品。  The prescribed amount of sea cucumber dFG 20mmol/L pH 7.0 PBS was weighed to the full amount and the solution was completed. Add 0.6% medicinal activated carbon, half 20 min; Buchner funnel and 3.0 μπι microporous filter ship carbon. Measuring intermediate ^ f:. After passing the test, use 0.22μιη micro-lUi membrane±consult; fill in the control vial, 0.5ml per bottle, monitor the filling volume during the filling process, half-press plug, freeze dry slag, ^^ freeze-drying curve Freeze-dried, tamped, out of the box, rolled, and qualified.
冻干过程: 将样品进箱, 降隔板温至 > 0。C, 保持 3h; 冷阱降至 -50。C, 开始抽 真空至 300nbar。 开始升华: lh匀速升温至 -30。C, ^ 2h; 2h匀速升温至 -20。C, Freeze-drying process: Place the sample into the box and lower the partition to >0. C, hold 3h; cold trap drops to -50. C, start pumping vacuum to 300nbar. Start sublimation: lh heat up to -30 at a constant rate. C, ^ 2h; 2h at a constant rate to -20. C,
8h, 真空^ 200 ~300 bar; 再进行干燥: 2h升温至 -5。C, ^ 2h, 真空  8h, vacuum ^ 200 ~ 300 bar; then dry: 2h to -5. C, ^ 2h, vacuum
150 ~ 200Mbar; 0.5h升温至 10。C, 2h,真空^ 80 ~ lOOnbar; 0.5h升温至 40。C, 150 ~ 200Mbar; 0.5h to 10. C, 2h, vacuum ^ 80 ~ lOOnbar; 0.5h to 40. C,
4h, 真空抽至最低。  4h, vacuum is drawn to the lowest.

Claims

^換求书 ^Change the book
1、 一种制^ ^藻糖 胺 »的方法, ^在^ N介盾中催化剂存在下, 催^ ill 解 藻糖條胺雜获 藻糖條胺歸, 其中:  1. A method for producing oxalate amines, ^ in the presence of a catalyst in the N-shi shield, urging ill sulphate miscible saponin, wherein:
所 ^藻糖 胺雑是指一类来源于棘皮动物糖胺雑或 生物, 其结构 特征为,所述 FG中含有摩尔比范围为 0.7-1.3的葡萄 乙 半 基 或^^酯, 并且含有岩藻糖或^ m醋基, 岩藻^ ^酯基与乙  Is a kind of echinoaraminin or organism derived from echinoderms, and its structural feature is that the FG contains a glucosyl group or a ketone of a molar ratio ranging from 0.7 to 1.3, and contains a rock. Alginose or ^ m vine, algae ^ ^ ester and B
酸酯的摩尔比范围为 0.5 ~2.5; The molar ratio of the acid ester ranges from 0.5 to 2.5;
所述催化剂为 ^^自元素周 四周期 度金属离子形成 化剂; 所述 ^藻^¾|胺 »是指其重均^ *为 6000 ~ 20000Da范围内的岩藻 糖條胺緣  The catalyst is a metal ion forming agent from the elemental cycle of the element; the algae ^3⁄4|amine » refers to a fucose amine edge having a weight average ^ * of 6000 ~ 20000Da
2、权^^求 1所述的方法,其中所述^ ^自元素周^ ^四周期 度金属离子 的催化剂;^ Cu+, Οι 、
Figure imgf000015_0001
Ni形成的;^盐 l ^机盐, 或其组合。
2. The method according to claim 1, wherein the ^^ is a catalyst of a metal ion of four cycles from the element; ^ Cu + , Οι ,
Figure imgf000015_0001
Formed by Ni; salt, salt, or a combination thereof.
3、权^ ^求 2所述的方法, 其中所述金属离子是  3. The method of claim 2, wherein the metal ion is
4、 权利要求 2所述的方法, 其中在反应体系中, 所述催化剂的浓度为 0.001mmol/L ~ 100mmolLo  4. The method of claim 2, wherein in the reaction system, the concentration of the catalyst is 0.001 mmol/L to 100 mmol Lo
5、权矛 J ^求 1所述的方法,其中所 选自 i¾乙酸、 化氢、 3-氯 -:^甲酸、 ! tl ^烯、 过^^钠、 itl t^曱 St 其盐或酯。  5, the right spear J ^ seeking 1 method, which is selected from i3⁄4 acetic acid, hydrogen, 3-chloro-: ^ formic acid, ! Tl ^ ene, sodium ^^, itl t ^ 曱 St its salt or ester.
6、权 求 5所述的方法, 其中所 为^化氢。  6. The method of claim 5, wherein the hydrogen is obtained.
7、权^ ^求 ^-项所述的方法, 其中在 体系中, 所述 FG的质量分数 为 0.05% ~ 15%, 1± ^ 的质量分^0.5%~30%, 所述催化剂的 ½^ 0.001 mmolL ~ 100 mmol/L。 δ ^的- ¾> 围为 10°C - 750C。 7. The method according to the invention, wherein in the system, the mass fraction of the FG is 0.05% to 15%, the mass fraction of 1±^ is 0.5% to 30%, and the catalyst is 1⁄2 ^ 0.001 mmolL ~ 100 mmol / L. The range of δ ^ - 3⁄4> is 10 ° C - 75 0 C.
8、权利要求 1·6^—项所述的方法,其中在反应体系中进一步包括 1 mmolL ~ l.Omol/L
Figure imgf000015_0002
所 ϋ^^/ 机^^自氯 、 氯化钟、 乙酸钠、 乙酸钾及它们的水 ^、 以及其组合。
The method according to claim 1, wherein the reaction system further comprises 1 mmol L to 1.0 mol/L.
Figure imgf000015_0002
ϋ^^/ Machine ^^ from chlorine, chlorinated clock, sodium acetate, potassium acetate and their water ^, and combinations thereof.
9、
Figure imgf000015_0003
1方'^ ^藻糖 胺 »或其药学上可 ^:的 盐和 /或酯,其中所述^ 藻糖 >R ^胺 含有摩尔比为 1 : 1 ±0.3的葡萄^^ 和乙 ©LS^ ' t或^ ^酯,
Figure imgf000015_0004
所述^ 藻糖 胺聚糖中,以 GalNAc作为i^'tt ^的! ¾¾^数不低于 80%,多錄指^; 1.0 - 2.0。
9,
Figure imgf000015_0003
a salt and/or an ester of the compound or a pharmaceutically acceptable salt thereof, wherein the glucan>R^amine contains a grape with a molar ratio of 1 : 1 ±0.3 ^ and B LS ^ ' t or ^ ^ ester,
Figure imgf000015_0004
Among the glycosaminoglycans, GalNAc is used as i^'tt ^! The number of 3⁄43⁄4^ is not less than 80%, and the number of multiple entries is ^; 1.0 - 2.0.
10、权^^求 9所述的 藻樹 胺^!或其药学上可 的盐和 /或酯, 其中所述 藻糖條胺 重均^ 1量为 10,000 Da -15,000 Da,多錄指数 为 1.2-1.6, 其以 GalNAc作为还原性末端的聚糖分子数不低于 90%。 10, find the right ^^ tree alginate amine 9 ^! Or a pharmaceutically salt thereof and / or esters, wherein the weight average amine fucose strip ^ 1 in an amount of 10,000 Da -15,000 Da, multiple index entries 1.2-1.6, the number of glycan molecules having GalNAc as a reducing end is not less than 90%.
11、 权利要求 40 项所述的低^藻糖化糖胺聚糖或其药学上可接受的盐 和 /或酯, 其中所 学上可 的盐为^ ^金属和 / ^i金属盐。  The hypoglycosylated glycosaminoglycan or a pharmaceutically acceptable salt and/or ester thereof according to claim 40, wherein the acceptable salts are metal and /^i metal salts.
14  14
更正页 (细则第 91条) Correction page (Article 91)
12、权 ^^求 11所述的 藻糖½ 胺»或其药学上可 的盐和 /或酯, 其中所述药学上可接受的盐为钠盐、钾盐和 4¾盐。 12. The sucrose 1⁄2 amine» or a pharmaceutically acceptable salt and/or ester thereof according to claim 11, wherein the pharmaceutically acceptable salts are sodium salts, potassium salts and salts.
13、一种药物组^ ^, 于, ^有效剂量的权^ ^求 9所述的 藻糖^ I胺!^或其药学上可 ^的盐和 /或酯, 以 学上可 ¾:的辅料。  13, a drug group ^ ^, in, ^ effective dose of the right ^ ^ seeking 9 described alginose ^ I amine! ^ or its pharmaceutically acceptable salts and / or esters, in order to learn from the auxiliary materials.
14、 求 9所述的 藻糖 胺聚糖或其药学上可 的盐和 /或酯在 制备血松 ϋ疾病的治疗和 /或预防药物中的用途。  14. Use of a sucrose glycosaminoglycan or a pharmaceutically acceptable salt and/or ester thereof according to the invention for the preparation of a medicament for the treatment and/or prevention of blood sputum disease.
15 15
更正页 (细則第 91条)  Correction page (Article 91)
PCT/CN2010/001679 2009-11-06 2010-10-25 Depolymerized fucosylated glycosaminoglycan and preparation method thereof WO2011054174A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2009101101140A CN101735336B (en) 2009-11-06 2009-11-06 Oligomeric fucosylated glycosaminoglycan and preparation method thereof
CN200910110114.0 2009-11-06

Publications (1)

Publication Number Publication Date
WO2011054174A1 true WO2011054174A1 (en) 2011-05-12

Family

ID=42459411

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/001679 WO2011054174A1 (en) 2009-11-06 2010-10-25 Depolymerized fucosylated glycosaminoglycan and preparation method thereof

Country Status (2)

Country Link
CN (1) CN101735336B (en)
WO (1) WO2011054174A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101735336B (en) * 2009-11-06 2012-07-18 深圳海王药业有限公司 Oligomeric fucosylated glycosaminoglycan and preparation method thereof
CN102247401A (en) * 2011-05-05 2011-11-23 中国科学院昆明植物研究所 Low molecular weight glycosylated chondroitin sulfate and its purpose in preparation of anti-HIV-1 medicament
CN102329397B (en) * 2011-10-19 2014-04-09 中国科学院昆明植物研究所 Fucosylated glycosaminoglycan derivative and preparation method thereof
CN103030707A (en) * 2012-12-30 2013-04-10 青岛市市立医院 Extraction method of holothuria atra glycosaminoglycan
EP2980103B1 (en) 2013-03-26 2020-11-04 Jiuzhitang Co., Ltd. Low molecular weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof
CN103214591B (en) 2013-04-12 2015-11-04 中国科学院昆明植物研究所 A kind of lower molecular weight osamine polysaccharid derivative of the talose or derivatives thereof that dewaters containing end 2,5-
CN103788222B (en) * 2014-01-08 2016-08-31 中国科学院昆明植物研究所 Substituted oligomeric glycosaminoglycans of Fuc3S4S and preparation method thereof
CN104370980B (en) * 2014-10-17 2017-12-01 九芝堂股份有限公司 A kind of oligosaccharide compound and its pharmaceutical composition for suppressing endogenous factors X enzymatic activitys
CN106349407A (en) * 2016-08-29 2017-01-25 中国海洋大学 Low-molecular-weight fucosylated chondroitin sulfate, preparation method thereof and application of low-molecular-weight fucosylated chondroitin sulfate to preparation of medicine for resisting Trousseau syndrome
CN108285498B (en) * 2017-01-10 2021-11-23 九芝堂股份有限公司 Oligosaccharide compound for inhibiting endogenous coagulation factor X enzyme complex and preparation method and application thereof
JP6980018B2 (en) * 2017-01-10 2021-12-15 九芝堂股▲ふん▼有限公司Jiuzhitang Co., Ltd. Oligosaccharides that inhibit the endogenous tennase complex, their production methods and uses
CN110724209B (en) * 2018-07-16 2021-11-19 烟台东诚药业集团股份有限公司 Fucosylated chondroitin sulfate oligosaccharide and preparation method, composition and application thereof
CN114252546A (en) * 2020-09-23 2022-03-29 牡丹江友搏药业有限责任公司 Method for determining content of low-molecular-weight fucosylated glycosaminoglycan
WO2022062011A1 (en) * 2020-09-24 2022-03-31 九芝堂股份有限公司 Method for purifying low-molecular weight fucosylated glycosaminoglycan by means of tangential flow ultrafiltration

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028191A (en) * 1995-08-24 2000-02-22 Centre National De La Recherche Scientifique (Cnrs) Method for obtaining sulphated polysaccharides
US20040087543A1 (en) * 2002-04-25 2004-05-06 Zachary Shriver Methods and products for mucosal delivery
CN1651470A (en) * 2004-02-04 2005-08-10 森德克斯股份有限公司 Low molecular weight heparin triethanolamine salt usable as local delivery antithrombotic treating agent, preparing process and use thereof
JP2007008899A (en) * 2005-07-04 2007-01-18 Mie Univ Vascularization inhibitor
CN101057859A (en) * 2007-05-14 2007-10-24 张登科 Depolymerization glycosaminoglycan extracted from sea cucumber composition and its preparation method and application
CN101735336A (en) * 2009-11-06 2010-06-16 深圳海王药业有限公司 Oligomeric fucosylated glycosaminoglycan and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1214609B (en) * 1985-05-17 1990-01-18 Opocrin Spa HEXOSAMINOGLICANS DEPOLYMERIZED SULPHATES FOR ANTI-THROMBOTIC, FIBRINOLITHIC, ANTI-INFLAMMATORY ACTIVITIES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028191A (en) * 1995-08-24 2000-02-22 Centre National De La Recherche Scientifique (Cnrs) Method for obtaining sulphated polysaccharides
US20040087543A1 (en) * 2002-04-25 2004-05-06 Zachary Shriver Methods and products for mucosal delivery
CN1651470A (en) * 2004-02-04 2005-08-10 森德克斯股份有限公司 Low molecular weight heparin triethanolamine salt usable as local delivery antithrombotic treating agent, preparing process and use thereof
JP2007008899A (en) * 2005-07-04 2007-01-18 Mie Univ Vascularization inhibitor
CN101057859A (en) * 2007-05-14 2007-10-24 张登科 Depolymerization glycosaminoglycan extracted from sea cucumber composition and its preparation method and application
CN101735336A (en) * 2009-11-06 2010-06-16 深圳海王药业有限公司 Oligomeric fucosylated glycosaminoglycan and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHENG, WENJING ET AL.: "Chemical CompomentAnalysis of Polysaccharides from Different Sea Cucumbers.", CHIN J MAR DRUGS., vol. 26, no. 1, February 2007 (2007-02-01), pages 44 - 49 *

Also Published As

Publication number Publication date
CN101735336A (en) 2010-06-16
CN101735336B (en) 2012-07-18

Similar Documents

Publication Publication Date Title
WO2011054174A1 (en) Depolymerized fucosylated glycosaminoglycan and preparation method thereof
Wang et al. Determination of the p K a of glucuronic acid and the carboxy groups of heparin by 13C-nuclear-magnetic-resonance spectroscopy
CN102329397B (en) Fucosylated glycosaminoglycan derivative and preparation method thereof
JPH0739442B2 (en) Novel heparin derivative and method for producing the same
JP6248179B2 (en) Low molecular weight glycosaminoglycan derivative comprising terminal 2,5-dehydrated talose or a derivative thereof
JP6472808B2 (en) Fuc3S4S-substituted low-molecular glycosaminoglycan and method for producing the same
HU188657B (en) Process for the preparation of anticoagulant mycopolysaccharides
WO2011063595A1 (en) Depolymerized glycosaminoglycan from thelenota ananas and preparation method thereof
CN103145868B (en) A kind of lower molecular weight osamine polysaccharid derivative and pharmaceutical composition thereof and its preparation method and application
NO820136L (en) PROCEDURE FOR THE PREPARATION OF IMPROVED ANTICOAGULATING SUBSTANCE
JP2010518238A (en) Low molecular weight heparins comprising at least one covalent bond with biotin or a biotin derivative, methods for their production and their use.
CN104370980B (en) A kind of oligosaccharide compound and its pharmaceutical composition for suppressing endogenous factors X enzymatic activitys
CA2907887C (en) Low-molecular-weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof
CN108285498B (en) Oligosaccharide compound for inhibiting endogenous coagulation factor X enzyme complex and preparation method and application thereof
CN109251255B (en) Fucosylated chondroitin sulfate FCShmAnd preparation method and application thereof
US20200254003A1 (en) Oligosaccharide compound for inhibiting intrinsic coagulation factor x-enzyme complex, and preparation method therefor and uses thereof
WO1990008784A1 (en) New sulfated polysaccharide, pharmaceutically acceptable salts thereof, preparation thereof, and drug containing the same as active ingredient
CN113666980A (en) High-selectivity factor Xa inhibitor heparin heptasaccharide and preparation method and application thereof
JPS624703A (en) Production of low-mw heparin fraction
CN110698522B (en) Odd-numbered chondroitin oligosaccharide monomer and preparation method and application thereof
CN111423523B (en) Oligosaccharide compound and pharmaceutically acceptable salt thereof, preparation method and application
KR20050024349A (en) Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10827788

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10827788

Country of ref document: EP

Kind code of ref document: A1